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Abstract
Background The amount of resources, particularly prepaid resources, available for health can affect access to health 
care and health outcomes. Although health spending tends to increase with economic development, tremendous 
variation exists among health financing systems. Estimates of future spending can be beneficial for policy makers 
and planners, and can identify financing gaps. In this study, we estimate future gross domestic product (GDP), 
all-sector government spending, and health spending disaggregated by source, and we compare expected future 
spending to potential future spending.
Methods We extracted GDP, government spending in 184 countries from 1980–2015, and health spend data from 
1995–2014. We used a series of ensemble models to estimate future GDP, all-sector government spending, 
development assistance for health, and government, out-of-pocket, and prepaid private health spending through 2040. 
We used frontier analyses to identify patterns exhibited by the countries that dedicate the most funding to health, and 
used these frontiers to estimate potential health spending for each low-income or middle-income country. All estimates 
are inflation and purchasing power adjusted.
Findings We estimated that global spending on health will increase from US$9·21 trillion in 2014 to $24·24 trillion 
(uncertainty interval [UI] 20·47–29·72) in 2040. We expect per capita health spending to increase fastest in upper-
middle-income countries, at 5·3% (UI 4·1–6·8) per year. This growth is driven by continued growth in GDP, 
government spending, and government health spending. Lower-middle income countries are expected to grow at 
4·2% (3·8–4·9). High-income countries are expected to grow at 2·1% (UI 1·8–2·4) and low-income countries are 
expected to grow at 1·8% (1·0–2·8). Despite this growth, health spending per capita in low-income countries is 
expected to remain low, at $154 (UI 133–181) per capita in 2030 and $195 (157–258) per capita in 2040. Increases in 
national health spending to reach the level of the countries who spend the most on health, relative to their level of 
economic development, would mean $321 (157–258) per capita was available for health in 2040 in low-income 
countries. 
Interpretation Health spending is associated with economic development but past trends and relationships suggest 
that spending will remain variable, and low in some low-resource settings. Policy change could lead to increased 
health spending, although for the poorest countries external support might remain essential.
Funding Bill & Melinda Gates Foundation.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Anticipation of future health spending and the source of 
that funding is vital for effective health policy. With 
reliable spending forecasts, decision makers can adjust 
long-term planning and processes. Investments can be 
made strategically to counter shortfalls or enhance growth 
in coming years. Because dependence on out-of-pocket 
health payments has been shown to reduce access to 
health services and increase medical impoverishment in 
some settings, understanding how funds will be collected, 
and if they will be prepaid and pooled across groups, is 
also of crucial importance.1–8 The source of health funding 
often dictates the types of services and supplies procured 
and how efficiently those resources are deployed.9–13 
Without careful planning, limited resources for health 
can translate into insufficient access to health services 
and an over-reliance on out-of-pocket payments.14
The health financing transition describes how health 
financing changes, on average, as countries develop 
economically: per capita health spending increases and 
out-of-pocket expenses comprise a smaller share of total 
health expenditure than previously.15 However, tre-
mendous variation in health financing systems and the 
associated levels of financing underpins these trends. 
In 2014, spending per capita in low-income countries 
varied from US$33 to $347, and per capita spending in 
high-income countries varied from $853 to $9237. The 
health financing transition is not guaranteed to continue 
as new countries progress through various stages of 
development. Prospective health spending estimates 
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show what past trends and relationships suggest 
regarding future spending and sources of those funds.
Development assistance for health is no longer an 
expanding resource for developing country health 
budgets. Tepid growth in this area since 2010 suggests 
that external funding will not grow at the rate seen 
earlier in the millennium. This prediction intensifies 
the need to increase domestic spending on health in 
some of the poorest countries. Fiscal space analyses 
have been done in a number of these countries to help 
prepare for the slowing down of development assistance 
for health growth.16,17 However, few studies have 
comprehensively and empirically assessed what 
forecasts of future income mean for government health 
spending and other sources of health financing.18–21 
Among the forecasting studies that do exist,22–24 few 
assess mechanisms that alter financing trajectories, 
such as future macroeconomic scenarios, changes in 
country prioritisation, technological advancements, and 
other developments.
The objective of this study is to empirically assess how 
existing health financing trends and relationships could 
be shifted and, more generally, how the need for health 
resources can be met in an ever-evolving global economy. 
Using novel methods, we estimated future gross domestic 
product (GDP), all-sector (also known as general) 
government spending, and health spending through to 
year 2040. We then assessed alternative scenarios in health 
financing, highlighting how fiscal policy changes (in 
government spending levels and the allocation of those 
resources) could affect future health spending. Together, 
economic forecast indicators and health spending 
estimates show expected and potential health expenditure, 
which are essential inputs to decision making as the 
global context becomes increasingly uncertain.
Methods
Overview
We estimated national GDP, all-sector government 
spending, and health spending for each year through 
Research in context
Evidence before this study
Forecasts of total health spending, and health spending 
disaggregated by source into government spending, out of 
pocket, prepaid private, and development assistance for health 
are crucial inputs into health-system planning. Understanding 
of the opportunity to alter these probable trajectories through 
plausible increases in the share of gross domestic product (GDP) 
spent by government or the share of government expenditure 
spent on health to expand fiscal space for health has also 
become an important dimension of health policy in the era of 
Sustainable Development Goals.
Country-specific forecasts have been developed for a few 
countries. The Organisation for Economic Co-operation and 
Development periodically produces forecasts to 2060 for its 
member states and the Brazil, Russia, India, China, and South 
Africa. The only comprehensive set of health expenditure 
forecasts covering a comprehensive set of countries has been 
produced by Dieleman and colleagues in 2016.
Added value of this study
This study advances our previous assessment of future health 
spending in three ways. First, a key driver of future health spending 
in total and by source is economic development, often measured 
by GDP per capita. Given that there is no regularly updated set of 
GDP forecasts that extends to 2040 and covers all countries with 
similar methods, we developed GDP forecasts. To improve on 
previous methods used to forecast GDP and follow good forecast 
practice applied in other fields, we switched to forecasting GDP 
using an ensemble of models. We developed 1664 models and 
selected the 136 that met predetermined inclusion criteria and had 
the best out-of-sample performance. These revised GDP forecasts 
are more optimistic than previous estimates for Luxembourg, 
Qatar, and especially China. Second, we modelled the share of GDP 
spent by government to derive all-sector government spending 
estimates. These forecasts allowed us to estimate government 
health spending as a share of all-sector government spending. 
These techniques better reflect the reality that health spending by 
government is constrained by the size of government. This 
two-stage modelling of government spending captures the direct 
competition for scarce government resources between sectors. 
Third, we studied the potential of low-income and middle-income 
countries to increase the amount spent on health by increasing the 
share of GDP spent by the government, increasing the share of 
government budgets spent on health, or both. This exploration of 
the fiscal space to increase health spending was not previously 
completed, and was done empirically by fitting a frontier to the 
observed spending patterns at each level of development. This 
study is the first, to our knowledge, to provide a prospective 
empirical assessment of the potential to increase health spending 
in all low-income and middle-income countries.
Implications of all the available evidence
Because of more optimistic forecasts of GDP from our ensemble 
modelling approach for low-income and middle-income 
countries and the ability to constrain estimates of government 
health spending to a plausible share of all-sector government 
spending, we have increased our forecasts of health expenditure 
in low-income countries from $34–357 per capita to $42–384. 
Despite these shifts, spending as a share of GDP will remain low 
and it is likely that small growth in development assistance for 
health will not fill the gap. Our assessment of fiscal space shows 
that although the optimal policy options vary by country, there 
is substantial potential to increase health expenditure if 
countries can achieve the levels of GDP spent by the government 
and the share of government budgets spent on health of some 
countries at the same level of development.
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to 2040 for 184 countries based on past trends of the 
relationships between demographic and financial data 
over time. Future health spending was estimated by 
source: government, out-of-pocket, and prepaid private 
health spending as well as developmental assistance for 
health received. These four source-specific spending 
estimates were aggregated to form total national health 
spending. All projections were similar and consistent, 
and were based on ensemble models. Ensemble models 
are a standard in some areas of forecasting and rely on 
the estimation of many individual models and pooling 
the results to form a single estimate with uncertainty 
intervals [UIs]. These types of models have been shown 
to be more accurate than traditional single specification 
models in some circumstances.25–27 Additionally, our 
models incorporated codependencies, such that macro-
economic variables and each of the health spending 
variables affected each other. These methods build on 
previously published research with substantive 
improvements and are described more thoroughly in the 
appendix.28 Figure 1 outlines the processes used to 
estimate future GDP, all-sector government spending, 
and health spending by source.
Data
We extracted health spending data for 184 countries 
spanning 1995 to 2014 from the Institute for Health 
Metrics and Evaluation’s Financing Global Health 2016 
database.14,29 These data track government health 
spending from domestic sources, including general 
budget support and social health insurance; prepaid 
private health spending, which includes private 
insurance and non-governmental organisation spending; 
out-of-pocket health spending, which includes all 
spending at point-of-service and copayments; and 
developmental assistance for health. The data were 
collated and missing values (1·7% of the government 
spending, 14·8% of prepaid private spending, and 1·7% 
of out-of-pocket health spending) were imputed with 
multiple imputation methods from Amelia II: a program 
for missing data in R.30 The final series of data were 
mutually exclusive and exhaustive estimates of total 
health spending in each country.
GDP and all-sector government spending data 
spanning 1980 to 2015 were based on data collected 
from the International Monetary Fund, the UN, the 
Maddison Project, and Penn World Tables database.31–35 
These data were combined with use of regression 
methods and previously developed for producing a 
complete GDP time series.36 All health spending, GDP, 
and all-sector government spending estimates from this 
database were reported in inflation-adjusted 2015 
purchasing power parity adjusted US$. 
Estimating future GDP 
We used an ensemble model that capitalised on past 
trends and relationships to predict GDP for 184 countries 
from 2016 through 2040.28 These models are based on 
data from 1980 to 2015. Altogether, 1664 models were 
considered to estimate the future growth rate of GDP, 
measured as the difference in natural log-transformed 
GDP. The independent variables considered were total 
population, share of the population younger than 20 years 
Input data Ensemble models
Demographic variables
GDP per capita
1980–2015
Population
1980–2040
Share of population
<20 years
1980–2040
Total fertility 
rate
1980–2040
Forecast GDP per capita
2016–40
 1664 models considered
 547 models passed criteria
All-sector government
spending
1980–2015
Forecast all-sector government
spending per GDP
2016–40
 128 models considered
 46 models passed criteria
DAH by source
1990–2016
Forecast DAH provided
 per GDP 2017–40
 381 models considered
 20 models passed criteria
DAH by recipients
1995–2014
Forecast DAH received per GDP
2015–40
 255 models considered
 14 models passed criteria
DAH transition
2017–40
Government, private
prepaid, and out-of-
pocket health spending
1995–2014
Forecast government health
spending per all-sector
government spending, and
prepaid private and out-of-
pocket health spending per GDP
2016–40
 8372 models considered
 1981 models passed criteria
Additional covariates
• All models are estimated using first-order differences 
 and country-specific random intercepts
• All ensemble models considered up to three degrees 
 of autoagressive terms
• GDP per capita ensemble models considered a 
 convergence term, up to three degrees of 
 autocorrelation, and four potential weighting 
 schemes across recent years and observations
• All-sector government spending ensemble models 
 considered up to one degree of autocorrelation
Figure 1: Process diagram for estimating future GDP, all-sector government spending, and health spending 
by source
The process diagram indicates the data used by each ensemble for estimating future GDP, all-sector government 
spending, government health spending, prepaid private health spending, out-of-pocket health spending, or DAH. 
The number of models considered is the universe of specific model specifications considered for that ensemble 
model. Each individual model was tested against three exclusion criteria. The number of models that passed each 
criterion is also indicated. DAH=development assistance for health. GDP=gross domestic product.
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of age, total fertility rate, and a convergence term, which 
is the 1 year lag of the non-differenced dependent variable. 
The 1664 models included all combinations of 
independent variables. More specific information about 
the universe of models, precise model specifications, and 
estimated coefficients are included in the appendix.
All models were assessed against three exclusion 
criteria. First, we excluded models with any independent 
variable that was not statistically significant (α=0·1). 
Second, we excluded models that estimated a coefficient 
greater than zero for the convergence term. Third, we 
excluded models that produced predictions that fell 
outside the bounds of growth observed in the underlying 
data (1980–2015; appendix). After implementation of 
these exclusion criteria, 547 models remained.
Of these 547 models, country forecasts were based on 
the best performing 25% of models (136 models). The best 
performing models were identified by the country-specific 
out-of-sample validation based on root-mean-squared 
error. To compute this, 10 years of observed data (2006–15) 
were withheld, the 547 models were rerun, and predicted 
values for 2006–15 were compared against actual values. 
The 136 models selected for each country-specific and 
year-specific models were rerun on the entire observed 
data set (1980–2015) to maximise use of observed data.
Uncertainty was propagated in three ways. First, we 
used the ensemble modelling framework to incorporate 
model uncertainty. Second, we took 74 random draws 
from the estimated variance-covariance matrix of each 
model to create more than 10 000 draws to incorporate 
parameter uncertainty. (74 random draws was the 
smallest number of draws that could be used for each of 
the 136 models to ensure at least 10 000 total draws.) 
Lastly, we added correlated periods of growth or recession 
across countries to model global recessions, and also 
added country-specific and year-specific periods of 
growth and recession to model otherwise unexpected 
country-specific growth or recession. We report a point-
estimate, and lower and upper confidence interval based 
on the mean, 2·5th and 97·5th percentile of the 
10 064 draws.
Estimating future all-sector government spending and 
health spending by source
All-sector government spending, out-of-pocket health 
spending, and prepaid private health spending were each 
modelled as a share of GDP with the same method used 
to estimate future GDP. Government health spending 
was modelled as a share of all-sector government spending 
with the same methods. For each of these models, GDP 
per capita (natural log-transformed) was included as a 
potential independent variable in the ensemble. For each 
of the three health spending ensembles, a 1 year lag of the 
other health spending variables and all-sector government 
spending per capita (natural log-transformed) was also 
included in the ensemble to ensure codependence across 
the health spending estimates.
We used a three-step process to estimate the amount of 
future development assistance for health disbursed to 
each low-income or middle-income country. These 
methods were based on previously published research.37 
First, we extracted development assistance for health 
provided by 24 major sources of development assistance 
and modelled development assistance for health provided 
as a share of the source’s GDP to make estimates of total 
development assistance for health provided through 2040. 
These sources of development assistance for health are 
generally national treasuries, for example, those of the 
USA or UK, or major donors such as the Bill & Melinda 
Gates Foundation. Second, we modelled development 
assistance for health received, measured as a share of the 
total amount of development assistance for health 
provided to each low-income or middle-income country 
through 2040. Finally, we estimated the transition of 
countries from middle-income to high-income status on 
the basis of GDP per capita estimates. This transition, 
estimated to be when GDP per capita surpasses 
$18 108 per capita, marks the point at which, according to 
our definition of development assistance for health, a 
country is no longer eligible to receive development 
assistance for health. To estimate expected total health 
spending, we summed development assistance for health 
received and government, prepaid private, and out-of-
pocket health spending.
Potential health and government health spending
To estimate potential health spending in low-income and 
middle-income countries, we used stochastic frontier 
analysis. In our analysis, this frontier represents the 
amount of spending generated by the countries with the 
most health spending given their level of economic 
development. In this case, the frontier represents 
potential spending, based on a country’s GDP per capita 
and peers’ health spending. For our frontier analyses, we 
assumed a half-normal distribution of residual, although 
the appendix shows robustness analyses exploring the 
effect of alternative assumptions. This analysis was 
completed with only low-income and middle-income 
countries because very few high-income countries are 
concerned with increasing spending on health.
We report potential total health spending per capita for 
low-income and middle-income countries by estimating 
the spending on health that would result if countries 
increased spending to the frontier level. Potential spending 
is greater than actual spending for most, but not all, 
countries, because the frontier level is above most country-
specific expected spending levels. The distance between a 
country’s expected (forecasted) spending level and the 
frontier represents potential increases in health spending.
Finally, we used an additional set of frontiers to analyse 
three policy scenarios that could be used to increase 
government health spending in low-income and middle-
income countries. In particular, we assessed how an 
increase in government spending and a reprioritisation of 
See Online for appendix
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government spending towards the health sector could 
separately and cumulatively increase government health 
spending. The first scenario supposed that governments 
are able to raise all-sector government spending, measured 
as a share of GDP, to reflect their highest spending peer. 
The second scenario supposed that governments are able 
to prioritise the health sector like their highest spending 
peers. And the third scenario supposed that governments 
are able to generate all-sector government spending in 
addition to prioritising the health sector like their highest 
spending peers. In each of these scenarios, the highest 
spending peers are identified using the frontier analysis. 
Precise specifications of these models are included in the 
appendix. Because it is more plausible that these gains 
could be made as a result of long-term policy changes, this 
analysis focused on the effect of health spending in 2040. 
All estimation and analysis was completed with Stata 
(version 13.1) and R (version 3.3.2). 
We report expected and potential spending estimates for 
each country, and for World Bank income groups and 
Global Burden of Disease super regions. Per capita and per 
GDP estimates reflect the entire group, meaning is the 
sum of spending divided by the sum of denominators 
World Bank income groups are four mutually exclusive 
categories assigned by the World Bank and based primarily 
on gross national income. Global burden of disease super 
regions are seven mutually exclusive categories based on 
geography and cause of death patterns.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. All authors had full access to the data in the 
study and JLD and CJLM had final responsibility for the 
decision to submit the manuscript.
Results
Table 1 presents data for health spending in 2014 and 
expected health spending in 2030 and 2040. These are 
shown in per capita terms and as a proportion of GDP. 
In 2014, $9·21 trillion was spent on health worldwide. 
Past trends and relationships suggest that, in 2030, 
$16·04 trillion (UI 14·50–17·78) will be spent on health 
and, in 2040, $24·24 trillion (20·47–29·72) will be spent 
on health. In per capita terms, this growth is from $1279 
in 2014 to $2872 (UI 2426–3522) in 2040, with an 
annualised rate of growth of 3·0% (2·4–3·8).
Figure 2 shows how per capita health spending is 
expected to increase between 2014 and 2040 in World 
Bank income groups and global burden of disease super 
2014 2030 2040 2014–40
Health 
spending 
per capita ($)
Health 
spending 
per GDP (%)
Health spending 
per capita ($)
Health spending per GDP 
(%)
Health spending 
per capita ($)
Health spending per 
GDP (%)
Annualised rate of 
change, health 
spending 
per capita (%)
Global 1279 8·3% 1983 (1793 to 2199) 8·2% (7·4 to 9·1) 2872 (2426 to 3522) 8·2% (7·0 to 10·1) 3·0% (2·4 to 3·8)
Income group
High income 5221 11·7% 7334 (6786 to 7815) 12·5% (11·5 to 13·3) 9215 (8475 to 9967) 13·1% (12·0 to 14·2) 2·1% (1·8 to 2·4)
Upper-middle income 914 5·9% 2072 (1698 to 2583) 6·4% (5·2 to 7·9) 3903 (2770 to 5741) 6·9% (4·9 to 10·1) 5·3% (4·1 to 6·8)
Lower-middle income 267 4·3% 525 (485 to 582) 4·7% (4·3 to 5·1) 844 (739 to 1004) 5·0% (4·4 to 6·0) 4·2% (3·8 to 4·9)
Low income 120 7·3% 154 (133 to 181) 6·6% (5·8 to 7·8) 195 (157 to 258) 6·7% (5·4 to 8·9) 1·8% (1·0 to 2·8)
GBD super region
Central Europe, eastern 
Europe, and central Asia
1364 6·7% 1877 (1766 to 2018) 6·9% (6·5 to 7·4) 2417 (2252 to 2637) 7·1% (6·6 to 7·7) 2·1% (1·9 to 2·4)
GBD high income 5460 12·3% 7643 (7076 to 8146) 13·1% (12·1 to 14·0) 9556 (8791 to 10337) 13·8% (12·7 to 14·9) 2·1% (1·8 to 2·4)
Latin America and Caribbean 1082 7·3% 1534 (1350 to 1745) 8·2% (7·2 to 9·3) 2047 (1720 to 2494) 8·9% (7·5 to 10·8) 2·3% (1·7 to 3·1)
North Africa and Middle East 870 5·2% 1246 (1137 to 1416) 5·8% (5·3 to 6·6) 1630 (1431 to 1975) 6·3% (5·5 to 7·6) 2·3% (1·8 to 3·0)
South Asia 223 4·2% 529 (467 to 619) 4·8% (4·2 to 5·6) 935 (773 to 1203) 5·3% (4·4 to 6·8) 5·3% (4·6 to 6·2)
Southeast Asia, east Asia, 
and Oceania
588 4·8% 1867 (1436 to 2471) 5·6% (4·3 to 7·4) 4035 (2640 to 6314) 6·3% (4·1 to 9·9) 7·0% (5·6 to 8·8)
Sub-Saharan Africa 218 5·9% 259 (238 to 286) 5·6% (5·2 to 6·2) 307 (269 to 365) 5·7% (5·0 to 6·8) 1·3% (0·8 to 1·9)
Country
Afghanistan 159 9·7% 201 (161 to 268) 10·2% (8·1 to 13·6) 249 (179 to 388) 10·6% (7·6 to 16·5) 1·6% (0·4 to 3·3)
Albania 642 5·9% 1202 (1022 to 1424) 6·6% (5·6 to 7·8) 1733 (1404 to 2144) 6·7% (5·5 to 8·3) 3·7% (2·9 to 4·5)
Algeria 1004 7·2% 1567 (1248 to 2146) 9·1% (7·2 to 12·4) 2080 (1439 to 3337) 10·4% (7·2 to 16·6) 2·6% (1·3 to 4·4)
Andorra 5723 8·1% 7230 (5789 to 8606) 8·6% (6·9 to 10·3) 8357 (5791 to 10773) 8·7% (6·1 to 11·3) 1·4% (0·0 to 2·3)
Angola 228 3·0% 256 (169 to 321) 2·5% (1·7 to 3·1) 308 (154 to 414) 2·5% (1·2 to 3·3) 1·0% (–1·5 to 2·2)
Antigua and Barbuda 1213 5·5% 2165 (1727 to 2767) 7·4% (5·9 to 9·4) 2987 (2175 to 4321) 8·5% (6·2 to 12·4) 3·3% (2·2 to 4·7)
(Table 1 continues on next page)
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2014 2030 2040 2014–40
Health 
spending 
per capita ($)
Health 
spending 
per GDP (%)
Health spending 
per capita ($)
Health spending per GDP 
(%)
Health spending 
per capita ($)
Health spending per 
GDP (%)
Annualised rate of 
change, health 
spending 
per capita (%)
(Continued from previous page)
Argentina 1322 4·8% 2177 (1769 to 2985) 5·7% (4·6 to 7·8) 3012 (2202 to 4807) 6·2% (4·6 to 10·0) 3·0% (1·9 to 4·8)
Armenia 395 4·5% 674 (549 to 907) 4·9% (4·0 to 6·7) 997 (727 to 1578) 5·3% (3·9 to 8·4) 3·4% (2·3 to 5·1)
Australia 4032 9·0% 5606 (5186 to 6165) 9·7% (9·0 to 10·7) 6970 (6206 to 8111) 10·2% (9·1 to 11·9) 2·0% (1·6 to 2·6)
Austria 5471 11·2% 7416 (6788 to 8143) 11·6% (10·6 to 12·7) 9257 (8270 to 10607) 12·0% (10·8 to 13·8) 1·9% (1·5 to 2·5)
Azerbaijan 1030 5·9% 1734 (1524 to 1978) 6·3% (5·5 to 7·2) 2502 (2033 to 3062) 6·5% (5·3 to 7·9) 3·3% (2·5 to 4·0)
Bahrain 2258 4·8% 3289 (2738 to 4136) 5·3% (4·4 to 6·7) 4380 (3426 to 6336) 5·8% (4·5 to 8·4) 2·4% (1·5 to 3·8)
Bangladesh 92 2·9% 173 (149 to 198) 2·8% (2·4 to 3·2) 266 (206 to 327) 2·8% (2·2 to 3·5) 3·9% (3·0 to 4·7)
Barbados 1116 7·5% 1641 (1412 to 1926) 8·7% (7·5 to 10·2) 2155 (1705 to 2736) 9·5% (7·5 to 12·0) 2·4% (1·6 to 3·3)
Belarus 1093 5·6% 1825 (1432 to 2308) 7·0% (5·5 to 8·9) 2369 (1648 to 3243) 7·4% (5·1 to 10·1) 2·8% (1·5 to 4·0)
Belgium 4751 10·6% 6437 (5759 to 7278) 11·2% (10·0 to 12·7) 8005 (6950 to 9572) 11·7% (10·2 to 14·0) 1·9% (1·4 to 2·6)
Belize 503 5·8% 678 (593 to 776) 6·3 %(5·5 to 7·2) 844 (703 to 1017) 6·6% (5·5 to 8·0) 1·9% (1·2 to 2·6)
Benin 105 5·1% 169 (134 to 221) 6·2% (4·9 to 8·1) 232 (161 to 357) 7·3% (5·0 to 11·2) 2·8% (1·6 to 4·5)
Bhutan 279 3·6% 563 (397 to 774) 3·5% (2·5 to 4·8) 940 (517 to 1558) 3·6% (2·0 to 5·9) 4·4% (2·3 to 6·4)
Bolivia 404 6·3% 673 (565 to 814) 7·3% (6·1 to 8·8) 943 (736 to 1252) 8·0% (6·3 to 10·7) 3·1% (2·2 to 4·2)
Bosnia and Herzegovina 992 9·5% 1734 (1331 to 2104) 10·4% (8·0 to 12·6) 2613 (1921 to 3416) 11·6% (8·6 to 15·2) 3·5% (2·4 to 4·6)
Botswana 903 5·5% 1395 (1168 to 1723) 6·3% (5·2 to 7·7) 1878 (1452 to 2524) 6·8% (5·3 to 9·2) 2·7% (1·8 to 3·8)
Brazil 1357 8·3% 1994 (1657 to 2402) 10·0% (8·3 to 12·1) 2770 (2150 to 3708) 11·3% (8·7 to 15·1) 2·6% (1·7 to 3·7)
Brunei 1811 2·6% 2254 (1741 to 3135) 3·5% (2·7 to 4·8) 2612 (1859 to 4315) 4·0% (2·8 to 6·5) 1·2% (0·1 to 3·2)
Bulgaria 1490 8·4% 2659 (2116 to 3624) 9·7% (7·7 to 13·2) 3870 (2896 to 5754) 10·7% (8·0 to 15·9) 3·5% (2·5 to 5·0)
Burkina Faso 83 5·0% 108 (93 to 127) 5·0% (4·3 to 5·9) 128 (101 to 168) 5·1% (4·0 to 6·6) 1·6% (0·7 to 2·6)
Burundi 65 8·3% 85 (62 to 120) 9·6% (7·0 to 13·6) 104 (65 to 176) 10·1% (6·3 to 17·1) 1·6% (0·0 to 3·7)
Cambodia 209 6·4% 397 (352 to 448) 6·0% (5·3 to 6·7) 642 (543 to 760) 6·1% (5·2 to 7·2) 4·1% (3·5 to 4·8)
Cameroon 116 4·0% 156 (135 to 179) 4·1% (3·5 to 4·7) 190 (150 to 238) 4·3% (3·4 to 5·4) 1·8% (0·9 to 2·6)
Canada 4576 10·3% 5926 (5389 to 6601) 10·7% (9·7 to 11·9) 7248 (6516 to 8528) 11·1% (10·0 to 13·1) 1·7% (1·3 to 2·3)
Cape Verde 318 4·8% 529 (412 to 686) 4·8% (3·8 to 6·3) 768 (523 to 1124) 5·0% (3·4 to 7·4) 3·2% (1·8 to 4·7)
Central African Republic 35 5·7% 46 (29 to 77) 9·4% (6·0 to 15·8) 58 (25 to 145) 13·8% (6·0 to 34·2) 1·5% (–1·2 to 5·3)
Chad 89 3·8% 111 (74 to 150) 3·9% (2·6 to 5·3) 138 (75 to 212) 4·2% (2·3 to 6·4) 1·5% (–0·7 to 3·2)
Chile 1780 7·8% 3217 (2622 to 3793) 8·8% (7·1 to 10·3) 4791 (3724 to 6105) 9·5% (7·4 to 12·1) 3·6% (2·7 to 4·6)
China 697 5·1% 2493 (1851 to 3402) 6·0% (4·5 to 8·2) 5703 (3571 to 9218) 6·7% (4·2 to 10·8) 7·7% (6·1 to 9·6)
Colombia 975 7·2% 1620 (1168 to 2206) 7·8% (5·7 to 10·7) 2398 (1616 to 3727) 8·5% (5·7 to 13·2) 3·2% (1·9 to 5·0)
Comoros 111 7·1% 121 (101 to 148) 8·6% (7·1 to 10·5) 132 (96 to 184) 9·8% (7·1 to 13·6) 0·6% (–0·5 to 1·9)
Congo (Brazzaville) 312 5·2% 424 (336 to 543) 6·1% (4·8 to 7·8) 544 (394 to 736) 7·1% (5·1 to 9·6) 2·0% (0·9 to 3·2)
Costa Rica 1418 9·3% 2142 (1628 to 2636) 9·0% (6·8 to 11·1) 3050 (2207 to 4077) 9·3% (6·8 to 12·5) 2·8% (1·6 to 3·9)
Côte d’Ivoire 179 5·3% 242 (214 to 275) 5·4% (4·8 to 6·1) 292 (246 to 352) 5·6% (4·7 to 6·7) 1·8% (1·2 to 2·5)
Croatia 1734 7·8% 2263 (2064 to 2445) 7·8% (7·1 to 8·5) 2795 (2482 to 3032) 8·2% (7·3 to 8·9) 1·8% (1·3 to 2·1)
Cuba 1706 11·1% 2326 (1635 to 3134) 11·3% (7·9 to 15·2) 3097 (2091 to 4454) 12·3% (8·3 to 17·7) 2·1% (0·8 to 3·6)
Cyprus 2019 7·2% 2864 (2520 to 3352) 8·0% (7·0 to 9·4) 3655 (3021 to 4619) 8·7% (7·2 to 10·9) 2·2% (1·5 to 3·1)
Czech Republic 2384 7·4% 3146 (2753 to 3657) 7·1% (6·3 to 8·3) 3856 (3240 to 4708) 7·3% (6·2 to 9·0) 1·8% (1·1 to 2·5)
DR Congo 46 4·5% 67 (52 to 86) 5·1% (3·9 to 6·6) 83 (56 to 123) 5·5% (3·8 to 8·2) 2·1% (0·8 to 3·7)
Denmark 5075 10·8% 6251 (5488 to 6890) 10·7% (9·4 to 11·8) 7373 (5855 to 8735) 10·8% (8·6 to 12·8) 1·4% (0·5 to 2·0)
Djibouti 357 10·9% 613 (486 to 838) 13·9% (11·0 to 18·9) 842 (598 to 1324) 15·6% (11·1 to 24·5) 3·1% (1·9 to 4·8)
Dominica 599 5·5% 859 (740 to 1012) 6·2% (5·3 to 7·3) 1092 (874 to 1406) 6·6% (5·3 to 8·5) 2·2% (1·4 to 3·2)
Dominican Republic 601 4·4% 1211 (930 to 1567) 4·9% (3·7 to 6·3) 1833 (1316 to 2498) 5·1% (3·7 to 6·9) 4·1% (2·9 to 5·3)
Ecuador 1071 9·2% 1491 (1261 to 1758) 10·2% (8·6 to 12·0) 1935 (1534 to 2410) 11·0% (8·7 to 13·7) 2·2% (1·3 to 3·0)
Egypt 581 5·4% 903 (820 to 1016) 5·5% (4·9 to 6·1) 1212 (1070 to 1453) 5·5% (4·9 to 6·6) 2·7% (2·3 to 3·4)
El Salvador 567 6·8% 1018 (826 to 1354) 7·7% (6·3 to 10·3) 1520 (1089 to 2337) 8·6% (6·1 to 13·2) 3·6 %(2·4 to 5·2)
Equatorial Guinea 1411 3·7% 1435 (1163 to 1792) 3·6% (2·9 to 4·5) 1746 (1302 to 2291) 3·8% (2·8 to 4·9) 0·8% (–0·3 to 1·8)
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Eritrea 59 5·1% 68 (53 to 88) 4·8% (3·7 to 6·2) 84 (56 to 129) 5·1% (3·4 to 7·9) 1·2% (–0·2 to 2·9)
Estonia 1830 6·4% 3274 (2683 to 4230) 7·9% (6·5 to 10·2) 4554 (3386 to 6301) 8·7% (6·5 to 12·1) 3·3% (2·3 to 4·6)
Ethiopia 85 5·5% 149 (115 to 197) 4·9% (3·8 to 6·5) 212 (153 to 311) 4·6% (3·3 to 6·7) 3·3% (2·2 to 4·8)
Federated States of 
Micronesia
490 16·1% 608 (359 to 972) 17·2% (10·1 to 27·5) 767 (302 to 1703) 19·4% (7·7 to 43·1) 1·3% (–1·8 to 4·6)
Fiji 399 4·5% 558 (503 to 614) 4·6% (4·1 to 5·0) 705 (630 to 804) 4·7% (4·2 to 5·4) 2·1% (1·7 to 2·6)
Finland 3935 9·3% 5061 (4654 to 5562) 9·5% (8·8 to 10·5) 6209 (5648 to 6920) 9·9% (9·0 to 11·1) 1·7% (1·3 to 2·1)
France 4589 11·3% 5963 (5487 to 6689) 11·6% (10·6 to 13·0) 7402 (6768 to 8671) 12·0% (11·0 to 14·1) 1·8% (1·4 to 2·4)
Gabon 612 3·4% 985 (799 to 1248) 4·7% (3·9 to 6·0) 1336 (966 to 1900) 5·8% (4·2 to 8·2) 2·8% (1·7 to 4·2)
Georgia 700 7·3% 1236 (1026 to 1427) 8·9% (7·4 to 10·3) 1608 (1268 to 1972) 9·2% (7·3 to 11·3) 3·1% (2·2 to 3·8)
Germany 5356 11·2% 7612 (6630 to 8575) 12·0% (10·5 to 13·5) 9659 (8134 to 11311) 12·7% (10·7 to 14·8) 2·2% (1·5 to 2·8)
Ghana 146 3·5% 218 (177 to 264) 3·7% (3·0 to 4·4) 288 (214 to 381) 3·8% (2·8 to 5·0) 2·5% (1·4 to 3·5)
Greece 2170 8·1% 2833 (2484 to 3383) 8·3% (7·3 to 9·9) 3462 (2923 to 4570) 8·6% (7·3 to 11·4) 1·7% (1·1 to 2·8)
Grenada 737 6·1% 1096 (967 to 1259) 6·3% (5·6 to 7·2) 1412 (1157 to 1755) 6·6% (5·4 to 8·2) 2·4% (1·7 to 3·2)
Guatemala 466 6·2% 594 (540 to 648) 6·2% (5·6 to 6·7) 715 (622 to 808) 6·3% (5·4 to 7·1) 1·6% (1·1 to 2·0)
Guinea 101 7·4% 127 (100 to 163) 7·9% (6·2 to 10·1) 165 (114 to 243) 8·9% (6·1 to 13·0) 1·8% (0·4 to 3·2)
Guinea-Bissau 77 5·3% 98 (75 to 131) 5·7% (4·4 to 7·6) 115 (74 to 194) 6·0% (3·9 to 10·2) 1·4% (–0·1 to 3·4)
Guyana 438 5·4% 685 (589 to 812) 5·8% (5·0 to 6·9) 903 (733 to 1142) 6·1% (5·0 to 7·7) 2·7% (1·9 to 3·5)
Haiti 154 8·9% 205 (164 to 262) 9·4% (7·5 to 12·0) 250 (178 to 385) 9·6% (6·8 to 14·7) 1·7% (0·5 to 3·4)
Honduras 420 8·8% 568 (513 to 654) 8·8% (8·0 to 10·1) 716 (625 to 887) 9·0% (7·9 to 11·2) 2·0% (1·5 to 2·8)
Hungary 1855 7·2% 2706 (2522 to 3028) 7·3% (6·8 to 8·2) 3441 (3140 to 4128) 7·5% (6·9 to 9·0) 2·3% (1·9 to 3·0)
Iceland 3959 8·7% 5491 (4824 to 6314) 9·2% (8·1 to 10·6) 6869 (5809 to 8455) 9·6% (8·1 to 11·8) 2·0% (1·4 to 2·8)
India 253 4·5% 629 (550 to 747) 5·1% (4·4 to 6·0) 1138 (927 to 1488) 5·6% (4·6 to 7·3) 5·5% (4·8 to 6·6)
Indonesia 265 2·5% 509 (443 to 588) 2·6% (2·3 to 3·0) 793 (640 to 986) 2·7% (2·2 to 3·4) 4·0% (3·3 to 4·9)
Iran 1073 6·5% 1558 (1263 to 1874) 7·3% (5·9 to 8·8) 2051 (1489 to 2709) 7·8% (5·7 to 10·4) 2·4% (1·2 to 3·4)
Iraq 828 5·7% 1018 (787 to 1401) 5·9% (4·6 to 8·2) 1230 (860 to 1897) 6·4% (4·5 to 9·9) 1·4% (0·1 to 3·1)
Ireland 4006 7·6% 5989 (4758 to 7222) 7·8% (6·2 to 9·4) 7363 (5145 to 9737) 8·1% (5·7 to 10·7) 2·2% (0·9 to 3·3)
Israel 2722 7·7% 3747 (3312 to 4249) 8·4% (7·4 to 9·5) 4534 (3695 to 5491) 8·7% (7·1 to 10·5) 1·9% (1·1 to 2·6)
Italy 3311 9·0% 4154 (3805 to 4502) 8·8% (8·1 to 9·6) 5135 (4580 to 5713) 9·2% (8·2 to 10·2) 1·6% (1·2 to 2·0)
Jamaica 477 5·4% 773 (650 to 955) 7·0% (5·9 to 8·6) 1000 (748 to 1399) 7·7% (5·8 to 10·8) 2·7% (1·7 to 4·0)
Japan 3816 10·2% 5729 (4452 to 6820) 11·7% (9·1 to 13·9) 7695 (6122 to 9315) 13·0% (10·3 to 15·7) 2·6% (1·8 to 3·3)
Jordan 839 7·4% 1097 (982 to 1226) 7·4% (6·6 to 8·3) 1335 (1144 to 1565) 7·6% (6·5 to 8·9) 1·7% (1·1 to 2·3)
Kazakhstan 1143 4·3% 1545 (1343 to 1817) 4·2% (3·6 to 4·9) 2047 (1787 to 2500) 4·3% (3·8 to 5·3) 2·1% (1·7 to 2·9)
Kenya 197 6·4% 237 (194 to 302) 5·9% (4·9 to 7·6) 286 (209 to 423) 6·1% (4·5 to 9·0) 1·3% (0·2 to 2·8)
Kiribati 168 9·6% 184 (81 to 281) 9·9% (4·4 to 15·2) 214 (58 to 386) 10·8% (2·9 to 19·6) 0·5% (–3·9 to 3·1)
Kuwait 2075 3·0% 3208 (2309 to 4950) 4·2% (3·0 to 6·5) 4368 (2792 to 8124) 4·9% (3·1 to 9·1) 2·6% (1·1 to 5·1)
Kyrgyzstan 236 6·9% 315 (272 to 369) 7·4% (6·4 to 8·6) 384 (302 to 492) 7·7% (6·1 to 9·9) 1·8% (0·9 to 2·7)
Laos 113 2·0% 186 (144 to 234) 1·5% (1·2 to 1·9) 285 (178 to 419) 1·4% (0·9 to 2·1) 3·3% (1·7 to 4·8)
Latvia 1427 5·9% 2036 (1833 to 2247) 5·8% (5·2 to 6·4) 2564 (2246 to 2898) 5·8% (5·1 to 6·6) 2·2% (1·7 to 2·6)
Lebanon 1060 6·4% 1484 (1222 to 1825) 6·3% (5·2 to 7·8) 1895 (1458 to 2499) 6·5% (5·0 to 8·5) 2·1% (1·2 to 3·2)
Lesotho 319 11·6% 521 (371 to 667) 12·3% (8·8 to 15·8) 726 (464 to 1010) 13·0% (8·3 to 18·0) 3·0% (1·4 to 4·3)
Liberia 345 39·3% 287 (257 to 333) 27·1% (24·3 to 31·4) 276 (224 to 373) 22·2% (18·0 to 29·9) –0·9% 
(–1·6 to 0·3)
Libya 751 5·0% 781 (534 to 1147) 6·8% (4·7 to 10·0) 979 (590 to 1637) 8·8% (5·3 to 14·7) 0·8% (–0·9 to 2·9)
Lithuania 1830 6·5% 2904 (2579 to 3381) 6·6% (5·9 to 7·7) 3871 (3242 to 4809) 6·7% (5·6 to 8·3) 2·8% (2·1 to 3·6)
Luxembourg 7105 6·9% 10 593 (9569 to 12306) 7·4% (6·7 to 8·6) 13 924 (11726 to 
17 455)
7·9% (6·6 to 9·9) 2·5% (1·9 to 3·3)
Macedonia 887 6·5% 1368 (1240 to 1504) 6·8% (6·2 to 7·5) 1742 (1549 to 1931) 6·9% (6·1 to 7·7) 2·5% (2·1 to 2·9)
(Table 1 continues on next page)
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Madagascar 52 3·7% 65 (54 to 80) 4·2% (3·5 to 5·2) 73 (56 to 106) 4·4% (3·4 to 6·4) 1·3% (0·3 to 2·7)
Malawi 148 12·9% 184 (148 to 233) 13·4% (10·8 to 17·0) 219 (160 to 320) 13·9% (10·1 to 20·2) 1·4% (0·3 to 2·9)
Malaysia 1047 4·1% 1783 (1576 to 2102) 4·1% (3·6 to 4·8) 2528 (2099 to 3249) 4·1% (3·4 to 5·3) 3·2% (2·6 to 4·2)
Maldives 1980 13·5% 3623 (2656 to 5154) 13·1% (9·6 to 18·6) 6070 (3725 to 9978) 13·9% (8·6 to 22·9) 4·0% (2·3 to 6·0)
Mali 162 7·4% 229 (193 to 275) 7·3% (6·2 to 8·8) 300 (231 to 402) 7·9% (6·1 to 10·6) 2·2% (1·3 to 3·4)
Malta 3058 9·7% 5997 (5097 to 7328) 12·1% (10·3 to 14·8) 8840 (6975 to 11 329) 13·5% (10·7 to 17·4) 3·9% (3·1 to 4·9)
Marshall Islands 599 17·2% 679 (495 to 851) 15·7% (11·5 to 19·7) 785 (448 to 1130) 15·8% (9·0 to 22·7) 0·9% (–1·1 to 2·3)
Mauritania 153 3·7% 204 (171 to 251) 4·0% (3·3 to 4·9) 258 (193 to 366) 4·4% (3·3 to 6·2) 1·9% (0·9 to 3·2)
Mauritius 880 4·6% 1942 (1454 to 2542) 5·5% (4·1 to 7·2) 3459 (2435 to 5042) 6·4% (4·5 to 9·4) 5·0% (3·8 to 6·5)
Mexico 1088 6·3% 1413 (1217 to 1611) 6·7% (5·8 to 7·7) 1726 (1403 to 2084) 7·1% (5·8 to 8·6) 1·7% (0·9 to 2·4)
Moldova 527 10·3% 711 (620 to 822) 10·5% (9·1 to 12·1) 910 (755 to 1122) 10·7% (8·8 to 13·1) 2·0%(1·3 to 2·8)
Mongolia 575 4·7% 1078 (837 to 1406) 4·7% (3·7 to 6·2) 1685 (1177 to 2462) 4·8% (3·4 to 7·0) 3·9% (2·7 to 5·4)
Montenegro 1015 6·6% 1613 (1373 to 2074) 7·5% (6·4 to 9·6) 2189 (1734 to 3138) 8·2% (6·5 to 11·8) 2·8% (2·0 to 4·2)
Morocco 505 5·9% 765 (700 to 833) 5·6% (5·2 to 6·1) 1056 (945 to 1160) 5·7% (5·1 to 6·2) 2·7% (2·3 to 3·1)
Mozambique 92 7·8% 96 (62 to 142) 5·3% (3·4 to 7·8) 117 (59 to 222) 4·9% (2·5 to 9·3) 0·7% (–1·6 to 3·3)
Myanmar 121 2·5% 394 (273 to 613) 3·3% (2·3 to 5·1) 979 (476 to 2210) 4·5% (2·2 to 10·1) 7·4% (5·1 to 10·8)
Namibia 936 9·3% 1437 (1277 to 1692) 9·8% (8·7 to 11·5) 1929 (1590 to 2499) 10·2% (8·4 to 13·2) 2·7% (2·0 to 3·6)
Nepal 138 5·8% 226 (197 to 259) 5·6% (4·9 to 6·5) 321 (263 to 388) 5·6% (4·6 to 6·7) 3·1% (2·4 to 3·8)
Netherlands 5234 10·7% 7799 (6370 to 9036) 12·2% (10·0 to 14·2) 10 186 (8436 to 
12 098)
13·4% (11·1 to 16·0) 2·5% (1·8 to 3·1)
New Zealand 4050 11·0% 5496 (4595 to 6193) 11·4% (9·5 to 12·9) 6868 (5624 to 8063) 11·9% (9·8 to 14·0) 1·9% (1·2 to 2·5)
Nicaragua 450 9·1% 652 (518 to 753) 9·3% (7·4 to 10·7) 830 (618 to 1005) 9·5% (7·1 to 11·5) 2·2% (1·2 to 3·0)
Niger 66 6·7% 81 (66 to 101) 6·8% (5·6 to 8·5) 98 (73 to 139) 7·3% (5·4 to 10·4) 1·4% (0·4 to 2·8)
Nigeria 225 3·7% 287 (245 to 343) 3·8% (3·2 to 4·5) 343 (268 to 449) 3·9% (3·0 to 5·1) 1·5% (0·6 to 2·6)
Norway 6537 10·0% 9758 (8486 to 11 459) 11·6% (10·1 to 13·6) 12 734 (10 505 to 
16 034)
12·7% (10·5 to 16·0) 2·4% (1·8 to 3·3)
Oman 1467 3·5% 2507 (1908 to 4034) 4·5% (3·4 to 7·2) 3631 (2369 to 7390) 5·2% (3·4 to 10·5) 3·1% (1·8 to 6·0)
Pakistan 132 2·7% 212 (184 to 250) 2·9% (2·6 to 3·5) 296 (237 to 383) 3·2% (2·6 to 4·2) 3·0% (2·2 to 4·0)
Panama 1743 8·0% 3094 (2659 to 3563) 8·0% (6·9 to 9·2) 4569 (3750 to 5565) 8·1% (6·7 to 9·9) 3·6% (2·8 to 4·3)
Papua New Guinea 108 4·4% 168 (139 to 206) 4·7% (3·9 to 5·7) 224 (167 to 304) 5·0% (3·8 to 6·8) 2·7% (1·6 to 3·8)
Paraguay 863 9·8% 1374 (1146 to 1760) 10·8% (9·0 to 13·8) 1916 (1460 to 2827) 11·6% (8·9 to 17·1) 2·9% (1·9 to 4·4)
Peru 626 5·2% 942 (807 to 1158) 5·3% (4·6 to 6·5) 1276 (1032 to 1692) 5·5% (4·5 to 7·3) 2·6% (1·9 to 3·7)
Philippines 330 4·7% 559 (494 to 624) 5·2% (4·6 to 5·8) 787 (661 to 920) 5·5% (4·6 to 6·4) 3·2% (2·6 to 3·8)
Poland 1629 6·3% 2836 (2528 to 3134) 5·9% (5·3 to 6·5) 4264 (3679 to 4873) 5·9% (5·1 to 6·7) 3·6% (3·0 to 4·1)
Portugal 2697 9·3% 3774 (3110 to 4600) 9·8% (8·1 to 12·0) 4784 (3934 to 6355) 10·5% (8·7 to 14·0) 2·1% (1·4 to 3·2)
Qatar 2663 2·2% 3785 (2922 to 5426) 2·7% (2·1 to 3·9) 5006 (3392 to 8591) 3·1% (2·1 to 5·3) 2·2% (0·9 to 4·3)
Romania 1077 5·5% 2258 (1703 to 3063) 6·8% (5·1 to 9·2) 3500 (2608 to 4864) 7·7% (5·7 to 10·7) 4·3% (3·3 to 5·6)
Russia 1877 7·1% 2287 (2100 to 2623) 7·5% (6·9 to 8·6) 2665 (2416 to 3206) 7·7% (7·0 to 9·3) 1·3% (0·9 to 2·0)
Rwanda 158 9·4% 217 (165 to 289) 8·5% (6·4 to 11·3) 278 (188 to 448) 8·4% (5·6 to 13·4) 2·0% (0·6 to 3·9)
Saint Lucia 755 6·7% 1023 (897 to 1212) 6·8% (6·0 to 8·1) 1340 (1086 to 1782) 7·4% (6·0 to 9·8) 2·1% (1·3 to 3·2)
Saint Vincent 
and the Grenadines
917 8·8% 1203 (968 to 1545) 8·7% (7·0 to 11·2) 1506 (1106 to 2137) 9·2% (6·8 to 13·1) 1·8% (0·7 to 3·1)
Samoa 365 7·2% 433 (338 to 643) 6·7% (5·2 to 9·9) 555 (403 to 856) 7·3% (5·3 to 11·2) 1·5% (0·4 to 3·2)
São Tomé and Príncipe 251 7·9% 317 (241 to 416) 8·1% (6·2 to 10·6) 397 (262 to 608) 8·9% (5·9 to 13·7) 1·6% (0·2 to 3·3)
Saudi Arabia 2320 4·4% 3355 (2554 to 5027) 5·3% (4·0 to 8·0) 4590 (3089 to 8043) 6·3% (4·2 to 11·1) 2·4% (1·1 to 4·6)
Senegal 121 5·2% 153 (130 to 184) 5·3% (4·5 to 6·4) 182 (140 to 245) 5·7% (4·4 to 7·7) 1·5% (0·5 to 2·6)
Serbia 1392 10·3% 1864 (1714 to 2037) 10·4% (9·6 to 11·4) 2319 (2113 to 2616) 10·7% (9·8 to 12·1) 1·9% (1·5 to 2·3)
Seychelles 853 3·3% 1599 (1118 to 2226) 4·0% (2·8 to 5·5) 2498 (1355 to 3834) 4·5% (2·5 to 7·0) 3·8% (1·7 to 5·6)
(Table 1 continues on next page)
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2014 2030 2040 2014–40
Health 
spending 
per capita ($)
Health 
spending 
per GDP (%)
Health spending 
per capita ($)
Health spending per GDP 
(%)
Health spending 
per capita ($)
Health spending per 
GDP (%)
Annualised rate of 
change, health 
spending 
per capita (%)
(Continued from previous page)
Sierra Leone 255 13·5% 250 (214 to 311) 15·7% (13·4 to 19·5) 290 (227 to 423) 15·9% (12·5 to 23·1) 0·4% (–0·4 to 1·9)
Singapore 3981 4·8% 6990 (5335 to 9135) 6·0% (4·6 to 7·9) 10 035 (7204 to 
14 611)
7·0% (5·0 to 10·2) 3·4% (2·2 to 4·8)
Slovakia 2203 7·7% 3798 (3306 to 4375) 8·0% (7·0 to 9·2) 5354 (4571 to 6557) 8·2% (7·0 to 10·1) 3·3% (2·7 to 4·0)
Slovenia 2845 9·1% 3970 (3482 to 4776) 9·4% (8·2 to 11·3) 4961 (4010 to 6494) 9·8% (7·9 to 12·8) 2·0% (1·3 to 3·1)
Solomon Islands 107 5·8% 111 (75 to 157) 4·9% (3·3 to 7·0) 141 (82 to 230) 5·4% (3·2 to 8·8) 0·9% (–1·0 to 2·8)
Somalia 33 6·9% 36 (27 to 50) 6·9% (5·2 to 9·5) 42 (27 to 72) 7·3% (4·7 to 12·4) 0·8% (–0·7 to 2·9)
South Africa 1172 8·9% 1499 (1346 to 1684) 9·7% (8·7 to 10·9) 1815 (1555 to 2165) 10·3% (8·9 to 12·3) 1·6% (1·0 to 2·3)
South Korea 2507 7·1% 4838 (4088 to 5783) 9·0% (7·6 to 10·8) 6859 (5323 to 8897) 10·1% (7·9 to 13·2) 3·7% (2·8 to 4·7)
South Sudan 94 3·6% 120 (84 to 182) 5·1% (3·6 to 7·7) 145 (78 to 283) 6·4% (3·4 to 12·5) 1·4% (–0·7 to 4·1)
Spain 3096 9·0% 4245 (3808 to 4645) 9·0% (8·0 to 9·8) 5194 (4510 to 5846) 9·1% (7·9 to 10·2) 1·9% (1·4 to 2·4)
Sri Lanka 402 3·5% 911 (716 to 1180) 3·8% (3·0 to 5·0) 1645 (1207 to 2289) 4·3% (3·1 to 5·9) 5·2% (4·1 to 6·4)
Sudan 334 8·3% 457 (380 to 543) 8·0% (6·6 to 9·5) 594 (478 to 730) 8·1% (6·5 to 9·9) 2·1% (1·3 to 2·9)
Suriname 731 4·3% 940 (765 to 1171) 4·2% (3·4 to 5·2) 1195 (856 to 1630) 4·3% (3·1 to 5·9) 1·8% (0·6 to 3·0)
Swaziland 745 9·5% 1132 (923 to 1430) 11·5% (9·4 to 14·5) 1467 (1062 to 2094) 12·8% (9·2 to 18·2) 2·4% (1·3 to 3·8)
Sweden 5446 11·8% 8048 (6984 to 9231) 13·1% (11·4 to 15·0) 10 194 (8079 to 
12 326)
13·9% (11·1 to 16·9) 2·3% (1·5 to 3·0)
Switzerland 7831 12·8% 9702 (8612 to 10 687) 13·4% (11·9 to 14·7) 11 365 (9797 to 
12 870)
14·0% (12·1 to 15·9) 1·4% (0·8 to 1·8)
Syria 562 3·4% 736 (618 to 908) 3·7% (3·1 to 4·5) 926 (703 to 1274) 4·0% (3·0 to 5·5) 1·8% (0·8 to 3·0)
Tajikistan 200 7·3% 309 (266 to 362) 8·9% (7·7 to 10·5) 398 (324 to 509) 9·8% (8·0 to 12·6) 2·5% (1·8 to 3·4)
Tanzania 166 6·4% 239 (194 to 303) 6·2% (5·0 to 7·8) 308 (225 to 445) 6·4% (4·6 to 9·2) 2·2% (1·1 to 3·6)
Thailand 633 4·1% 1113 (861 to 1390) 4·3% (3·4 to 5·4) 1689 (1315 to 2326) 4·7% (3·7 to 6·5) 3·6% (2·7 to 4·8)
The Bahamas 1996 7·7% 2658 (2387 to 3054) 8·6% (7·7 to 9·8) 3306 (2792 to 4163) 9·1% (7·7 to 11·5) 1·8% (1·2 to 2·7)
The Gambia 151 9·2% 174 (138 to 228) 10·2% (8·1 to 13·4) 199 (134 to 326) 11·4% (7·7 to 18·6) 0·9% (–0·4 to 2·8)
Timor-Leste 105 1·9% 216 (139 to 329) 3·0% (2·0 to 4·6) 302 (155 to 532) 3·5% (1·8 to 6·1) 3·7% (1·5 to 6·0)
Togo 81 5·5% 114 (99 to 134) 6·1% (5·2 to 7·1) 142 (113 to 187) 6·4% (5·1 to 8·4) 2·1% (1·2 to 3·1)
Tonga 253 5·3% 399 (279 to 594) 6·4% (4·5 to 9·5) 553 (352 to 954) 7·6% (4·8 to 13·1) 2·8% (1·2 to 4·9)
Trinidad and Tobago 1823 5·8% 2518 (2216 to 2919) 6·3% (5·5 to 7·3) 3177 (2671 to 4034) 6·5% (5·5 to 8·3) 2·0% (1·4 to 2·9)
Tunisia 791 6·9% 1099 (992 to 1232) 7·2% (6·5 to 8·1) 1390 (1195 to 1653) 7·5% (6·4 to 8·9) 2·1% (1·5 to 2·7)
Turkey 1040 5·3% 1748 (1556 to 2032) 5·7% (5·1 to 6·6) 2441 (2096 to 3065) 6·0% (5·1 to 7·5) 3·1% (2·6 to 4·0)
Turkmenistan 396 2·3% 925 (763 to 1132) 2·7% (2·2 to 3·3) 1638 (1237 to 2191) 3·0% (2·3 to 4·1) 5·2% (4·2 to 6·3)
Uganda 347 18·1% 313 (262 to 370) 11·6% (9·7 to 13·7) 384 (307 to 489) 11·6% (9·3 to 14·8) 0·3% (–0·5 to 1·3)
Ukraine 659 7·0% 673 (584 to 781) 7·5% (6·5 to 8·7) 715 (557 to 899) 7·7% (6·0 to 9·7) 0·3% (–0·6 to 1·1)
United Arab Emirates 2561 3·6% 3290 (2724 to 4287) 4·2% (3·4 to 5·4) 4182 (3227 to 6245) 4·6% (3·5 to 6·8) 1·8% (0·9 to 3·3)
UK 3749 9·1% 5002 (4276 to 5803) 9·3% (7·9 to 10·8) 6169 (5056 to 7605) 9·6% (7·9 to 11·8) 1·8% (1·1 to 2·6)
USA 9237 16·6% 12 448 (11 293 to 
13 528)
17·7% (16·0 to 19·2) 15 026 (13 412 to 
16 776)
18·5% (16·5 to 20·7) 1·8% (1·4 to 2·2)
Uruguay 1837 8·6% 2766 (2289 to 3130) 8·9% (7·4 to 10·1) 3716 (2963 to 4400) 9·3% (7·4 to 11·1) 2·6% (1·8 to 3·2)
Uzbekistan 397 5·9% 802 (648 to 1024) 7·2% (5·8 to 9·2) 1299 (931 to 1894) 8·3% (6·0 to 12·1) 4·3% (3·2 to 5·8)
Vanuatu 149 5·4% 214 (145 to 331) 7·3% (5·0 to 11·3) 283 (162 to 524) 8·9% (5·1 to 16·5) 2·2% (0·3 to 4·7)
Venezuela 1010 5·3% 1125 (988 to 1277) 5·7% (5·0 to 6·5) 1285 (1082 to 1528) 6·0% (5·1 to 7·2) 0·9% (0·3 to 1·5)
Vietnam 398 7·0% 919 (740 to 1123) 7·6% (6·1 to 9·2) 1545 (1121 to 2038) 7·9% (5·8 to 10·5) 5·0% (3·8 to 6·0)
Yemen 233 5·8% 229 (179 to 299) 7·0% (5·5 to 9·1) 276 (197 to 400) 7·4% (5·3 to 10·7) 0·6% (–0·6 to 2·0)
Zambia 216 5·4% 287 (232 to 363) 5·6% (4·5 to 7·1) 345 (251 to 497) 5·7% (4·2 to 8·2) 1·7% (0·6 to 3·1)
Data in parentheses are uncertainty intervals. Data are 2015 purchasing power parity US$. GDP=gross domestic product. GBD=global burden of disease.
Table 1: Expected health spending in 2030 and 2040
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regions. This growth is inflation and purchasing power 
adjusted. Health spending growth is highest in the 
groups that already spend the most on health. For 
example, high-income countries, which spent $5221 per 
capita in 2014, are expected to increase spending by 
$3994 (UI 3254–4746) between 2014 and 2040 and upper-
middle-income countries, which spent $914 in 2014, are 
expected to increase per capita spending by $2989 
(1856–4827). Meanwhile, lower-middle-income countries, 
which spent $267 per capita in 2014, are expected to 
increase spending by $577 (UI 472–737), and low-income 
countries, which spent $120 in 2014 are expected to 
increase spending by $75 (39–137). Sub-Saharan Africa is 
expected to increase spending from $218 per capita in 
2014 by $89 (UI 51–147).
In terms of growth rates, the middle-income countries 
are expected to grow much faster than low-income and 
high-income country groups. Upper-middle-income 
countries are expected to grow the fastest of the income 
groups at 5·3% (UI 4·1–6·8), whereas lower-middle 
income countries are expected to grow only a little slower 
at 4·2% (3·8–4·9). A slower growth rate is expected in 
low-income countries 1·8% (UI 1·0–2·8) and in high-
income countries at 2·1% (1·8–2·4).
The growth in per capita health spending shown in 
figure 2 will largely be driven by increases in government 
health spending. Globally, government health spending 
per capita will increase by $1126 (UI 697–1763) 
between 2014 and 2040. Gains will be largest in high-
income countries. The next largest increase in government 
spending is estimated to be in southeast Asia, eastern 
Asia, and Oceania; additionally major increases in per 
capita government spending are expected in China and 
Maldives. Out-of-pocket and prepaid private health 
financing are also expected to grow, although less than 
growth in government spending. In low-income and 
middle-income countries, development assistance for 
health per capita is expected to increase by only $3·2 
(UI –4·0 to 19·5) globally between 2014 and 2040.
Underpinning these trends, tremendous variation in 
the levels of health spending exists. In 2014, health 
spending per capita ranged from $33 in Somalia to 
$9237 in the USA. In 2040, national spending is expected 
to span an even larger range: from $42 (UI $23–72) in 
Somalia to $15026 ($13 412–16 776) in the USA. We 
estimated that spending in countries that were considered 
low-income in 2016 would grow from $120 per capita 
in 2014 to $154 (UI 133–181) per capita in 2030, and $195 
(157–258) per capita in 2040. For lower-middle-income 
countries, we expect 2030 per capita spending will grow 
from $267 to $525 (UI 485–582) and to $844 (738–1004) in 
2040. Upper-middle-income countries are expected to 
increase per capita health spending from $914 to $2072 
(UI 1698–2583) in 2030 and to $3903 (2770–5741) in 2040. 
Finally, we expect high-income countries to increase per 
capita spending from $5221 in 2014 to $7334 (UI 6786–7815) 
in 2030 and $9215 (8475–9967) in 2040.
Table 2 shows that the share of health spending 
financed by governments is expected to increase as well. 
This increase is true at the global level and for all World 
Bank 2016 income groups and all global burden of disease 
super regions. Government spending as a share of the 
total is expected to increase the most in upper-middle-
income countries, whereas the share of government 
spending is expected to increase by only a little, 
from 59·2% in 2014 to 65·3% (UI 58·7–72·3) in 2040, 
although total health spending is expected to increase 
substantially. Globally, the share of health spending that 
is financed through out-of-pocket payments is expected to 
decrease from 22·8% in 2014 to 21·4% (UI 16·5–26·2) 
in 2040. This proportion is expected to drop in 164 of 
184 countries included in this study.
Figure 3 shows the frontiers associated with potential 
total health spending, all-sector government spending, 
and government health spending. All three panels show 
an upward sloping frontier, meaning that more potential 
spending is associated with larger GDP per capita or all-
sector government spending. The gap between the 
frontier and individual countries suggests that many 
countries might be able to divert more resources to health.
Table 3 (columns 2 and 3) provides country-specific 
estimates of the additional resources available if each 
low-income and middle-income country increased health 
spending to its predicted potential, as determined by 
GDP per capita and the frontier. The frontier analysis 
suggests that low-income countries as a whole could 
spend 64·3% (UI 13·0–115·1) more on health, across all 
sources, if all countries spent as much as their highest 
spending peers. Overall, lower-middle-income countries 
would spend 80·7% (UI 26·2–139·0) more and upper-
middle-income countries would spend 19·9% (0·0–94·0) 
more, if all countries spent at the level marked by the 
World Bank income groups
High income
Upper-middle income
Lower-middle income
Low income
GBD super regions
Global burden of disease high income
Central Europe, eastern Europe, and central Asia
Latin America and Caribbean
North Africa and Middle East
Southeast Asia, east Asia, and Oceania
South Asia
Sub-Saharan Africa
0 2000 4000 6000 8000
Health spending per capita ($)
 Government health spending
 Prepaid private health spending
 Out-of-pocket health spending
 Development assistance for 
 health
Figure 2: Increases in health spending by source, 2016 World Bank income group, and GBD super region in 
2014–40
Per capita spending is measured in 2015 purchasing power parity US$. The left side of each bar marks the 
2014 health spending for each group. The right side of the bar represents the expected 2040 health spending. 
The bar shows the expected increase in health spending between 2014 and 2040, and highlights the source of the 
spending growth. GBD=global burden of disease.
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2014 2040
Government 
spending as 
share of total  
(%)
Prepaid private 
spending as 
share of total (%)
Out-of-pocket 
spending as 
share of total (%)
Development 
assistance for 
health as share 
of total (%)
Government 
spending as share 
of total (%)
Prepaid private 
spending as share 
of total (%)
Out-of-pocket 
spending as share 
of total (%)
Development 
assistance for health 
as share of total (%)
Global
Total 59·2% 17·4% 22·8% 0·6% 65·3% (58·7–72·3) 12·9% (10·1–16·0) 21·4% (16·5–26·2) 0·4% (0·1–0·9)
Income level
High income 63·4% 22·7% 13·9% 0% 65·5% (62·0–68·5) 22·0% (19·7–25·2) 12·5% (11·2–13·9) 0·0% (0·0–0·0)
Upper-middle income 57·2% 8·7% 33·8% 0·3% 71·2% (59·3–82·6) 6·4% (3·9–9·6) 22·3% (12·8–32·9) 0·0% (0·0–0·1)
Lower-middle income 35·9% 3·1% 58% 3% 45·6% (38·5–54·5) 2·7% (2·2–3·2) 50·5% (42·1–57·2) 1·2% (0·4–2·7)
Low income 18% 17·2% 29·1% 35·7% 29·4% (20·8–38·3) 14·4% (10·4–18·1) 29·9% (21·9–37·0) 26·3% (12·1–44·9)
GBD super region
Central Europe, eastern 
Europe, and central Asia
58·5% 2·8% 38·5% 0·3% 62·5% (57·7–65·8) 3·2% (2·7–4·2) 34·1% (31·0–39·1) 0·2% (0·0–0·5)
Global Burden of 
Disease high income
62·8% 23·4% 13·8% 0% 64·8% (61·2–67·9) 22·8% (20·4–26·0) 12·5% (11·2–13·9) 0·0% (0·0–0·0)
Latin America 
and Caribbean
51·6% 16·1% 31·7% 0·7% 59·6% (52·1–67·4) 14·7% (11·3–19·1) 25·5% (20·3–30·9) 0·2% (0·1–0·5)
North Africa and Middle 
East
60·1% 4·3% 34·9% 0·7% 63·9% (58·6–70·5) 3·9% (3·1–4·8) 31·6% (25·7–36·6) 0·6% (0·2–1·4)
South Asia 31% 2·6% 64·7% 1·7% 43·5% (33·0–56·6) 2·1% (1·5–2·5) 54·0% (41·5–64·1) 0·4% (0·1–1·1)
Southeast Asia, 
East Asia, and Oceania
58·6% 5·2% 35·7% 0·5% 73·2% (58·8–85·7) 4·9% (2·7–8·1) 21·8% (11·0–35·1) 0·1% (0·0–0·2)
Sub-Saharan Africa 33·5% 20·8% 29·2% 16·6% 39·0% (32·0–45·4) 15·5% (12·7–18·0) 31·1% (25·6–36·3) 14·4% (5·9–27·3)
Country
Afghanistan 15% 0% 54·1% 30·9% 19·1% (9·0–43·0) 0·5% (0·3–0·9) 50·2% (30·7–65·9) 30·1% (15·1–53·4)
Albania 48·3% 0% 49·8% 1·9% 58·1% (49·4–68·0) 0·8% (0·6–1·0) 41·0% (31·2–49·6) 0·1% (0·0–1·2)
Algeria 72·7% 0·7% 26·5% 0% 80·7% (72·4–89·0) 0·6% (0·3–1·0) 18·7% (10·6–26·7) 0·0% (0·0–0·1)
Andorra 78% 6% 15·9% 0% 78·5% (69·5–84·4) 6·5% (4·5–9·9) 15·0% (10·5–21·5) 0·0% (0·0–0·0)
Angola 70% 0% 26·6% 3·4% 61·9% (32·3–76·0) 2·3% (1·5–4·4) 32·7% (19·8–59·5) 3·1% (0·7–8·5)
Antigua and Barbuda 68·3% 8% 23·7% 0% 77·6% (68·9–85·4) 6·4% (4·1–9·4) 16·0% (10·1–23·2) 0·0% (0·0–0·0)
Argentina 55·8% 13·2% 30·9% 0% 65·0% (53·6–79·7) 11·3% (6·5–16·3) 23·7% (13·3–33·3) 0·0% (0·0–0·0)
Armenia 40·6% 3% 52·8% 3·6% 52·8% (40·1–71·7) 3·3% (1·9–5·3) 42·3% (25·0–54·7) 1·5% (0·0–6·0)
Australia 70·4% 9·9% 19·7% 0% 72·0% (66·7–76·7) 9·8% (7·8–12·7) 18·2% (14·8–23·3) 0·0% (0·0–0·0)
Austria 78% 5·8% 16·2% 0% 79·3% (76·0–82·6) 5·7% (4·6–8·1) 15·0% (12·4–17·6) 0·0% (0·0–0·0)
Azerbaijan 20·9% 4·3% 74·2% 0·6% 26·5% (18·1–39·1) 4·1% (3·0–5·8) 69·4% (57·2–77·9) 0·0% (0·0–0·0)
Bahrain 65·3% 10·6% 24·1% 0% 71·8% (64·1–81·2) 9·9% (6·3–14·3) 18·3% (12·1–24·1) 0·0% (0·0–0·0)
Bangladesh 22·7% 0% 65·6% 11·7% 30·2% (21·3–42·6) 1·8% (1·4–2·4) 63·6% (51·0–73·1) 4·5% (0·8–11·6)
Barbados 63·5% 6·6% 29·9% 0% 69·2% (60·0–77·1) 6·1% (4·3–8·8) 24·7% (17·7–33·3) 0·0% (0·0–0·0)
Belarus 66·9% 0·1% 32·6% 0·4% 68·2% (55·0–79·0) 0·8% (0·5–1·3) 31·0% (20·3–44·0) 0·0% (0·0–0·0)
Belgium 77·9% 4·3% 17·8% 0% 79·9% (76·6–83·6) 4·1% (3·2–5·2) 16·1% (12·9–18·8) 0·0% (0·0–0·0)
Belize 64·7% 9·5% 23% 2·9% 68·2% (61·2–74·8) 9·7% (7·3–13·1) 19·8% (15·2–24·7) 2·3% (0·5–5·7)
Benin 35% 0% 35·5% 29·6% 56·1% (39·3–73·7) 1·2% (0·6–2·0) 25·7% (15·6–36·3) 16·9% (6·0–34·4)
Bhutan 70·7% 0% 25·1% 4·2% 76·0% (58·4–88·1) 1·6% (0·8–2·7) 22·2% (10·7–39·0) 0·2% (0·0–1·9)
Bolivia 70·2% 3·4% 23·1% 3·3% 77·5% (70·1–84·2) 2·9% (1·8–4·6) 18·2% (12·4–24·6) 1·5% (0·4–3·6)
Bosnia and Herzegovina 70% 0% 28% 2% 78·8% (70·6–86·4) 0·5% (0·3–0·6) 20·4% (12·9–28·2) 0·4% (0·0–2·3)
Botswana 49·9% 35% 5·1% 10% 60·7% (49·2–72·1) 34·5% (24·2–45·2) 4·2% (2·9–5·7) 0·6% (0·0–7·0)
Brazil 45·9% 28·5% 25·5% 0·1% 56·1% (44·4–68·3) 24·8% (17·5–33·0) 19·1% (13·0–26·1) 0·0% (0·0–0·1)
Brunei 93·9% 0·1% 6% 0% 94·0% (89·4–97·0) 1·4% (0·8–2·1) 4·6% (2·1–8·9) 0·0% (0·0–0·0)
Bulgaria 54·7% 0·9% 44·3% 0·2% 61·1% (49·5–75·1) 0·7% (0·4–1·3) 38·3% (24·4–49·7) 0·0% (0·0–0·0)
Burkina Faso 35·8% 0% 38·6% 25·6% 40·5% (28·9–50·5) 1·1% (0·7–1·7) 38·1% (27·5–48·9) 20·3% (7·9–38·7)
Burundi 23·7% 0% 19·1% 57·2% 36·2% (17·2–55·4) 0·8% (0·4–1·4) 16·9% (8·9–26·8) 46·1% (23·0–71·0)
Cambodia 14·2% 0% 65·4% 20·4% 25·0% (15·1–34·8) 1·0% (0·7–1·5) 67·3% (56·9–77·7) 6·7% (1·6–16·5)
(Table 2 continues on next page)
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2014 2040
Government 
spending as 
share of total (%)
Prepaid private 
spending as 
share of total (%)
Out-of-pocket 
spending as 
share of total (%)
Development 
assistance for 
health as share 
of total (%)
Government 
spending as share 
of total (%)
Prepaid private 
spending as share 
of total (%)
Out-of-pocket 
spending as share 
of total (%)
Development 
assistance for health 
as share of total (%)
(Continued from previous page)
Cameroon 17% 3·5% 68·5% 10·9% 24·9% (16·1–37·7) 3·4% (2·5–4·8) 63·4% (51·0–73·8) 8·3% (2·9–17·8)
Canada 72·1% 14·1% 13·8% 0% 74·8% (71·5–79·1) 12·9% (10·7–14·8) 12·3% (9·6–14·7) 0·0% (0·0–0·0)
Cape Verde 58·4% 0·1% 22·2% 19·2% 68·4% (52·9–80·4) 1·2% (0·7–2·0) 21·9% (14·1–31·4) 8·6% (1·2–21·4)
Central African Republic 9% 0% 34·2% 56·7% 10·1% (2·9–20·1) 0·5% (0·1–1·0) 18·4% (5·8–36·2) 71·0% (44·8–90·7)
Chad 48·5% 1·3% 37·2% 12·9% 51·0% (20·7–71·8) 1·6% (0·8–2·8) 36·0% (20·2–60·4) 11·5% (3·3–26·6)
Chile 49·5% 19% 31·5% 0% 57·1% (45·8–67·0) 16·0% (12·1–20·7) 26·8% (20·1–34·5) 0·0% (0·0–0·0)
China 60·3% 5% 34·6% 0% 74·7% (59·1–87·5) 4·9% (2·6–8·3) 20·4% (9·3–34·8) 0·0% (0·0–0·0)
Colombia 71·9% 9·5% 15·3% 3·2% 77·8% (67·8–86·7) 10·4% (6·0–15·9) 11·7% (6·5–17·6) 0·1% (0·0–1·5)
Comoros 22·1% 20·1% 42·8% 14·9% 26·0% (14·2–43·2) 16·4% (11·4–22·1) 38·6% (25·3–52·3) 19·0% (6·6–39·8)
Congo (Brazzaville) 80·7% 0·3% 17·4% 1·7% 84·5% (77·2–89·6) 0·7% (0·5–1·1) 13·5% (8·9–20·5) 1·2% (0·4–3·1)
Costa Rica 73·1% 1·8% 25% 0% 73·5% (63·8–81·4) 1·8% (1·3–2·6) 24·6% (17·1–33·9) 0·0% (0·0–0·0)
Côte d’Ivoire 22·1% 8·2% 54·6% 15·1% 30·5% (22·4–40·6) 8·3% (6·2–10·9) 50·3% (41·2–58·7) 10·9% (3·7–22·9)
Croatia 81·9% 6·9% 11·2% 0% 81·9% (77·8–84·9) 7·5% (6·1–10·2) 10·7% (8·0–14·4) 0·0% (0·0–0·0)
Cuba 95·5% 0% 4·4% 0·2% 95·4% (93·1–97·1) 0·4% (0·3–0·6) 4·1% (2·6–6·3) 0·0% (0·0–0·2)
Cyprus 46% 4·4% 49·6% 0% 54·2% (45·6–64·5) 4·3% (3·0–6·2) 41·4% (32·0–49·4) 0·0% (0·0–0·0)
Czech Republic 84·8% 0·8% 14·4% 0% 85·1% (81·7–88·3) 0·9% (0·7–1·5) 14·0% (10·9–17·3) 0·0% (0·0–0·0)
DR Congo 21·3% 0% 37·4% 41·3% 33·6% (18·8–53·0) 1·0% (0·6–1·7) 35·5% (21·0–50·8) 29·9% (11·9–53·6)
Denmark 84·8% 1·9% 13·4% 0% 84·3% (80·1–87·5) 2·2% (1·7–3·3) 13·4% (10·5–17·1) 0·0% (0·0–0·0)
Djibouti 58·3% 0% 34·6% 7·1% 67·6% (54·9–81·4) 0·3% (0·2–0·5) 27·3% (15·7–38·4) 4·8% (1·4–11·4)
Dominica 68·7% 3% 28·3% 0% 73·0% (64·4–80·7) 2·7% (1·8–4·1) 24·3% (17·1–32·7) 0·0% (0·0–0·1)
Dominican Republic 63·4% 11·4% 21% 4·2% 74·0% (63·3–82·7) 11·1% (7·3–16·5) 14·9% (8·6–22·4) 0·0% (0·0–0·0)
Ecuador 48·8% 2·2% 48·5% 0·5% 53·1% (42·1–63·7) 2·0% (1·4–3·0) 44·6% (34·3–55·4) 0·3% (0·0–0·8)
Egypt 39·9% 1·5% 58·3% 0·2% 39·5% (33·5–49·5) 1·7% (1·2–2·5) 58·8% (49·0–64·7) 0·0% (0·0–0·2)
El Salvador 64·7% 4·9% 28·8% 1·6% 73·8% (63·5–84·5) 4·8% (2·7–7·6) 20·7% (11·8–29·8) 0·6% (0·0–2·1)
Equatorial Guinea 79·2% 0% 20·7% 0·1% 77·1% (65·6–84·4) 1·4% (1·0–1·9) 21·5% (14·5–33·1) 0·0% (0·0–0·0)
Eritrea 23·4% 0% 35·2% 41·4% 26·4% (12·4–42·3) 1·1% (0·7–1·7) 35·5% (21·5–50·9) 37·1% (16·6–61·2)
Estonia 79% 0·3% 20·8% 0% 82·1% (74·5–88·6) 0·6% (0·4–0·8) 17·3% (10·9–24·9) 0·0% (0·0–0·0)
Ethiopia 26·9% 0% 28·4% 44·7% 38·8% (24·2–53·2) 1·3% (0·7–2·0) 31·9% (19·6–43·9) 28·0% (9·6–52·3)
Federated States of 
Micronesia
0% 0% 7·7% 92·3% 8·3% (2·4–19·4) 0·3% (0·1–0·7) 7·9% (2·9–16·9) 83·5% (64·6–94·3)
Fiji 63·8% 7·5% 23% 5·7% 64·2% (57·0–69·8) 8·2% (6·4–10·7) 22·6% (18·3–29·5) 4·9% (1·2–12·0)
Finland 78% 3·1% 18·9% 0% 79·2% (76·5–82·0) 3·1% (2·6–4·0) 17·7% (15·0–20·2) 0·0% (0·0–0·0)
France 79·9% 13·6% 6·5% 0% 80·0% (76·2–83·5) 14·2% (11·4–17·8) 5·9% (4·5–7·1) 0·0% (0·0–0·0)
Gabon 67·4% 8·8% 22% 1·8% 81·0% (72·9–87·8) 5·3% (3·3–8·3) 13·3% (8·1–20·0) 0·4% (0·0–2·2)
Georgia 19·4% 18·9% 59·1% 2·6% 23·4% (15·5–36·1) 31·8% (20·8–40·9) 43·4% (33·4–54·3) 1·4% (0·0–4·9)
Germany 77·3% 9·4% 13·3% 0% 79·8% (75·8–83·2) 8·3% (6·8–10·0) 12·0% (9·7–14·6) 0·0% (0·0–0·0)
Ghana 52·8% 3·1% 27·1% 17% 61·1% (47·5–72·6) 3·1% (2·1–4·9) 25·6% (18·0–35·2) 10·2% (3·4–21·5)
Greece 61·7% 3·4% 34·9% 0% 63·4% (56·8–72·4) 3·9% (2·8–5·7) 32·7% (24·6–38·8) 0·0% (0·0–0·0)
Grenada 46·6% 2% 51·2% 0·2% 51·2% (42·8–62·1) 2·4% (1·8–3·0) 46·4% (35·8–54·6) 0·1% (0·0–0·3)
Guatemala 36·9% 8·2% 52·1% 2·8% 38·3% (31·3–45·5) 8·6% (7·2–10·8) 50·6% (43·8–57·1) 2·4% (0·7–5·7)
Guinea 20·4% 0% 34·5% 45·1% 40·2% (22·9–57·8) 1·0% (0·5–1·5) 31·2% (19·7–44·4) 27·6% (11·1–50·7)
Guinea-Bissau 6% 0% 52·1% 41·9% 3·2% (1·4–6·8) 0·9% (0·5–1·3) 48·1% (26·7–69·6) 47·8% (24·9–71·1)
Guyana 53·5% 2·9% 36·5% 7·1% 57·6% (47·4–67·7) 3·0% (2·1–4·3) 34·8% (26·2–44·2) 4·7% (1·2–11·5)
Haiti 0% 29·6% 29·6% 40·8% 1·1% (0·3–2·9) 34·4% (21·3–46·8) 27·6% (16·6–38·4) 37·0% (15·9–60·3)
Honduras 47·2% 5% 43·3% 4·6% 50·9% (44·3–60·8) 5·3% (3·7–7·5) 40·6% (32·2–46·9) 3·2% (0·6–7·8)
Hungary 68·1% 4·4% 27·5% 0% 68·6% (63·0–74·2) 4·1% (3·3–4·8) 27·3% (22·3–33·1) 0·0% (0·0–0·0)
Iceland 82·3% 0% 17·7% 0% 83·2% (79·7–86·8) 0·5% (0·4–0·6) 16·3% (12·7–19·8) 0·0% (0·0–0·0)
(Table 2 continues on next page)
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India 31·3% 2·4% 65·6% 0·7% 43·7% (32·5–57·5) 1·9% (1·4–2·4) 54·3% (41·0–65·2) 0·1% (0·0–0·4)
Indonesia 42·7% 2·7% 53·5% 1·1% 47·7% (37·3–58·8) 3·0% (2·0–4·4) 49·3% (38·5–59·4) 0·1% (0·0–0·6)
Iran 43·8% 5·3% 50·8% 0% 47·0% (30·6–61·0) 5·9% (3·9–9·1) 47·1% (34·1–62·8) 0·0% (0·0–0·0)
Iraq 58·2% 3% 38·4% 0·5% 62·1% (47·9–76·9) 3·3% (1·9–5·0) 34·4% (21·0–47·4) 0·2% (0·0–0·7)
Ireland 67·6% 14·3% 18·1% 0% 66·8% (53·3–76·2) 16·1% (11·2–23·6) 17·1% (11·8–24·5) 0·0% (0·0–0·0)
Israel 61·5% 11·2% 27·3% 0% 62·0% (53·7–69·4) 11·9% (9·1–15·7) 26·1% (20·7–32·4) 0·0% (0·0–0·0)
Italy 77·4% 0·9% 21·7% 0% 78·0% (72·0–83·1) 0·9% (0·8–1·1) 21·0% (16·0–27·2) 0·0% (0·0–0·0)
Jamaica 50·5% 19·4% 27·8% 2·3% 62·5% (50·8–74·1) 15·7% (10·4–21·9) 20·3% (13·9–27·1) 1·5% (0·2–4·3)
Japan 83·6% 2·4% 13·9% 0% 86·6% (82·9–89·5) 2·3% (1·7–3·6) 11·1% (8·5–14·2) 0·0% (0·0–0·0)
Jordan 66·8% 8% 21·1% 4·1% 67·4% (60·5–74·0) 9·2% (7·1–12·0) 20·2% (14·9–26·3) 3·2% (0·0–7·8)
Kazakhstan 54·4% 0% 45·3% 0·3% 55·3% (49·0–63·8) 1·2% (0·9–1·4) 43·5% (35·3–49·8) 0·0% (0·0–0·0)
Kenya 37·8% 3·8% 23·4% 35% 39·5% (25·5–58·4) 4·9% (3·2–6·6) 25·6% (16·1–35·2) 30·1% (12·4–51·7)
Kiribati 79·3% 0% 2·8% 17·9% 68·3% (22·4–90·8) 0·6% (0·3–1·8) 3·1% (1·3–8·9) 27·9% (6·7–71·0)
Kuwait 85·9% 1·3% 12·7% 0% 89·9% (83·0–95·2) 1·1% (0·6–1·7) 9·0% (4·1–15·6) 0·0% (0·0–0·0)
Kyrgyzstan 47·7% 1·3% 37·3% 13·7% 52·4% (40·5–64·3) 1·3% (0·9–2·0) 34·6% (25·2–44·6) 11·6% (3·9–24·7)
Laos 28·3% 0·4% 36·6% 34·7% 44·4% (25·5–65·7) 3·6% (2·0–6·3) 41·9% (23·9–61·4) 10·1% (0·0–32·5)
Latvia 63·2% 1·7% 35·1% 0% 63·4% (56·5–70·4) 2·0% (1·5–3·5) 34·6% (27·4–41·5) 0·0% (0·0–0·0)
Lebanon 47·6% 14·9% 36·4% 1·1% 50·5% (38·3–63·9) 16·2% (11·7–21·5) 33·1% (22·1–43·4) 0·2% (0·0–1·4)
Lesotho 63·4% 0·3% 15% 21·3% 70·7% (52·5–83·0) 0·5% (0·3–0·8) 12·6% (7·8–20·0) 16·3% (5·3–34·8)
Liberia 0% 0% 7·8% 92·2% 1·8% (0·2–6·5) 0·3% (0·2–0·4) 13·8% (9·8–17·8) 84·2% (78·5–89·1)
Libya 73·5% 0% 26·5% 0% 82·0% (65·1–91·6) 0·6% (0·3–1·0) 17·3% (8·0–34·2) 0·1% (0·0–0·4)
Lithuania 67·9% 0·8% 31·3% 0% 66·9% (60·2–73·8) 0·9% (0·6–1·3) 32·3% (25·5–38·8) 0·0% (0·0–0·0)
Luxembourg 83·9% 5·5% 10·6% 0% 85·3% (81·6–89·0) 5·5% (4·0–8·1) 9·2% (6·6–11·6) 0·0% (0·0–0·0)
Macedonia 63·1% 0% 36·6% 0·3% 62·1% (56·6–68·2) 0·7% (0·6–0·9) 37·2% (31·0–42·7) 0·0% (0·0–0·3)
Madagascar 29·5% 0% 34·3% 36·2% 39·0% (26·0–50·4) 1·3% (0·8–2·1) 30·5% (19·9–41·2) 29·2% (12·3–52·0)
Malawi 33·5% 14% 9·3% 43·1% 46·4% (30·2–60·7) 12·7% (8·0–17·8) 8·8% (5·6–12·7) 32·1% (14·2–54·8)
Malaysia 56% 8·1% 35·8% 0% 56·3% (48·5–67·3) 9·8% (6·9–13·5) 34·0% (24·4–41·4) 0·0% (0·0–0·0)
Maldives 79·4% 2% 18·5% 0% 78·1% (66·0–87·7) 2·3% (1·2–3·9) 19·6% (11·0–30·5) 0·0% (0·0–0·0)
Mali 22% 10·9% 43·6% 23·5% 36·8% (24·3–52·0) 9·6% (5·9–14·7) 38·3% (27·1–49·3) 15·2% (5·3–31·3)
Malta 69·2% 2% 28·9% 0% 78·0% (71·0–84·6) 1·7% (1·2–2·5) 20·4% (14·0–27·0) 0·0% (0·0–0·0)
Marshall Islands 62·9% 2·1% 11·8% 23·2% 63·1% (38·6–79·2) 2·6% (1·5–4·6) 13·0% (8·1–21·8) 21·3% (6·7–45·4)
Mauritania 44·5% 1·4% 44·7% 9·3% 53·3% (40·2–68·7) 1·5% (0·9–2·1) 38·6% (25·6–50·8) 6·7% (2·2–14·9)
Mauritius 50·8% 0·7% 48% 0·4% 65·7% (53·1–79·1) 0·9% (0·5–1·7) 33·3% (20·2–45·7) 0·0% (0·0–0·0)
Mexico 51·7% 4·2% 44% 0·1% 55·5% (45·3–63·6) 4·6% (3·4–6·5) 39·8% (32·2–49·9) 0·0% (0·0–0·1)
Moldova 47·2% 8·2% 38·3% 6·3% 47·2% (37·8–56·9) 9·4% (6·9–13·5) 38·9% (29·9–48·5) 4·5% (0·3–15·3)
Mongolia 51·4% 0·9% 41·9% 5·8% 57·4% (42·2–73·6) 1·2% (0·8–2·0) 41·2% (25·4–56·3) 0·2% (0·0–2·6)
Montenegro 55·3% 2·7% 41·4% 0·6% 62·2% (52·7–74·3) 2·4% (1·4–4·0) 35·4% (24·1–44·5) 0·0% (0·0–0·3)
Morocco 33·1% 7·6% 58·4% 0·9% 30·5% (24·9–35·3) 8·8% (7·2–11·3) 60·3% (55·4–65·7) 0·4% (0·0–1·2)
Mozambique 10·6% 0·6% 8·5% 80·2% 16·7% (4·9–37·3) 1·1% (0·5–2·1) 17·3% (8·1–31·1) 64·9% (38·9–84·6)
Myanmar 36·2% 0% 45·6% 18·2% 73·5% (51·8–90·7) 1·5% (0·5–2·9) 23·7% (8·3–44·0) 1·3% (0·0–8·3)
Namibia 53·5% 31·2% 6·9% 8·4% 61·8% (53·2–71·7) 29·2% (21·8–36·0) 6·2% (4·4–8·3) 2·8% (0·0–9·9)
Nepal 28·6% 5·9% 47·7% 17·8% 37·1% (29·3–46·4) 6·6% (4·7–9·7) 47·5% (37·6–55·3) 8·8% (1·5–21·3)
Netherlands 88·4% 6·3% 5·3% 0% 90·0% (87·1–92·2) 5·6% (4·3–7·8) 4·3% (3·1–6·4) 0·0% (0·0–0·0)
New Zealand 82·3% 6·6% 11% 0% 83·1% (78·9–86·4) 7·1% (5·4–9·5) 9·8% (7·5–12·4) 0·0% (0·0–0·0)
Nicaragua 50·9% 3·8% 37·3% 8% 54·9% (40·6–64·3) 4·1% (2·9–6·2) 35·9% (27·4–48·1) 5·1% (0·9–12·5)
Niger 26·3% 0% 49·5% 24·2% 39·8% (25·4–58·1) 0·8% (0·5–1·3) 45·4% (30·5–58·9) 14·0% (4·6–32·1)
Nigeria 22·1% 0·8% 70·1% 7% 24·7% (12·3–41·3) 1·5% (1·0–2·2) 67·1% (51·5–79·7) 6·8% (2·2–14·8)
(Table 2 continues on next page)
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Norway 83·1% 3·7% 13·2% 0% 86·8% (83·6–90·0) 3·1% (2·2–4·5) 10·1% (7·5–12·8) 0·0% (0·0–0·0)
Oman 91·8% 2·3% 5·9% 0% 93·6% (89·8–97·2) 1·9% (0·8–3·1) 4·5% (1·8–7·8) 0·0% (0·0–0·0)
Pakistan 32·1% 6·1% 55·4% 6·4% 47·6% (37·1–60·6) 5·4% (3·8–7·8) 42·9% (31·8–52·6) 4·1% (1·3–9·3)
Panama 72·5% 4·5% 22·3% 0·8% 75·0% (68·3–81·7) 5·4% (4·0–7·4) 19·6% (13·5–25·6) 0·0% (0·0–0·0)
Papua New Guinea 60·1% 3·9% 10·1% 25·9% 74·0% (59·3–84·6) 1·9% (1·3–2·6) 9·7% (6·2–14·5) 14·4% (4·9–29·8)
Paraguay 45·6% 4·6% 49·3% 0·5% 54·4% (42·3–70·2) 4·2% (2·6–6·1) 41·1% (26·7–52·7) 0·2% (0·0–0·7)
Peru 63·3% 6·3% 30% 0·4% 66·0% (57·3–75·5) 6·2% (4·4–9·1) 27·7% (19·4–35·8) 0·1% (0·0–0·5)
Philippines 33·6% 10·2% 54·3% 1·9% 43·1% (33·4–51·6) 10·3% (8·0–13·6) 45·7% (38·0–54·2) 0·9% (0·2–2·3)
Poland 71·4% 5% 23·6% 0% 72·4% (66·4–78·9) 6·0% (4·5–9·1) 21·6% (15·4–27·1) 0·0% (0·0–0·0)
Portugal 66·6% 5·9% 27·6% 0% 67·5% (59·1–77·1) 6·8% (4·5–9·6) 25·7% (17·6–34·1) 0·0% (0·0–0·0)
Qatar 85·7% 7·4% 6·9% 0% 89·1% (82·9–94·4) 6·1% (3·1–10·0) 4·8% (2·1–9·0) 0·0% (0·0–0·0)
Romania 79·1% 0·4% 18·9% 1·6% 86·6% (81·0–91·5) 0·7% (0·5–1·1) 12·7% (7·9–18·1) 0·0% (0·0–0·0)
Russia 51·8% 2·8% 45·5% 0% 53·2% (43·9–58·7) 3·0% (2·2–4·5) 43·9% (38·4–53·6) 0·0% (0·0–0·0)
Rwanda 0% 22·4% 22·6% 55% 1·7% (0·4–5·0) 28·1% (16·1–40·7) 27·3% (15·6–39·5) 42·9% (20·5–66·7)
Saint Lucia 49·2% 0·8% 45·6% 4·4% 58·9% (49·6–70·1) 0·9% (0·6–1·4) 37·6% (27·3–46·0) 2·6% (0·0–8·6)
Saint Vincent 
and the Grenadines
46·1% 2% 48·2% 3·6% 51·1% (37·0–67·1) 1·7% (1·0–3·3) 44·6% (29·6–58·1) 2·5% (0·0–7·6)
Samoa 87·2% 0% 5·9% 6·9% 84·9% (73·9–92·5) 0·7% (0·4–1·0) 5·8% (3·3–8·4) 8·5% (2·6–19·3)
São Tomé and Príncipe 31·1% 8% 11·9% 49% 47·3% (27·7–65·4) 5·9% (3·2–9·9) 10·6% (5·8–17·1) 36·2% (15·9–60·2)
Saudi Arabia 78·7% 6·2% 15·1% 0% 82·7% (74·4–91·2) 5·5% (2·7–8·7) 11·7% (5·8–18·7) 0·0% (0·0–0·0)
Senegal 39·4% 0% 33·8% 26·9% 46·8% (33·6–60·2) 1·1% (0·7–1·7) 31·9% (22·3–41·9) 20·3% (7·8–38·5)
Serbia 62·5% 0·3% 37% 0·1% 61·9% (55·4–66·5) 0·5% (0·4–0·8) 37·6% (33·0–44·1) 0·0% (0·0–0·3)
Seychelles 93·6% 4% 2·4% 0·1% 96·0% (92·4–97·9) 2·5% (1·3–5·3) 1·5% (0·6–3·1) 0·0% (0·0–0·0)
Sierra Leone 5·1% 9·2% 50·1% 35·6% 7·4% (4·0–12·0) 9·0% (5·6–12·3) 49·0% (32·7–63·0) 34·7% (22·0–55·1)
Singapore 42·4% 1·9% 55·7% 0% 56·2% (41·2–71·0) 1·7% (1·0–2·8) 42·1% (27·9–56·7) 0·0% (0·0–0·0)
Slovakia 76·3% 0% 23·7% 0% 77·5% (71·1–84·3) 0·6% (0·5–0·8) 21·9% (15·1–28·3) 0·0% (0·0–0·0)
Slovenia 73·2% 14·5% 12·3% 0% 73·1% (66·4–80·1) 15·6% (11·2–21·0) 11·3% (8·1–14·2) 0·0% (0·0–0·0)
Solomon Islands 67% 0% 4% 29·1% 55·9% (30·8–78·4) 1·0% (0·6–1·7) 4·5% (2·5–7·6) 38·5% (15·8–64·9)
Somalia 25% 1·2% 28·5% 45·2% 24·5% (11·6–38·0) 1·2% (0·6–2·0) 28·5% (15·5–42·2) 45·8% (22·4–70·7)
South Africa 47% 44·2% 6·4% 2·4% 53·8% (46·3–61·7) 38·7% (31·8–45·3) 5·2% (3·8–6·6) 2·4% (0·0–6·2)
South Korea 56% 6·6% 37·4% 0% 66·7% (57·0–75·7) 5·9% (4·0–8·9) 27·4% (19·6–35·8) 0·0% (0·0–0·0)
South Sudan 21% 0% 40·7% 38·3% 27·5% (9·1–58·3) 0·9% (0·4–1·5) 23·9% (11·0–40·1) 47·7% (20·0–75·4)
Spain 71·1% 4·8% 24·1% 0% 71·2% (64·4–76·8) 4·7% (3·9–6·2) 24·1% (18·4–31·0) 0·0% (0·0–0·0)
Sri Lanka 54·5% 1% 42·3% 2·1% 62·8% (50·6–74·2) 1·7% (1·0–2·7) 35·6% (24·6–47·1) 0·0% (0·0–0·0)
Sudan 20·4% 0·9% 76·6% 2·2% 22·9% (14·1–32·0) 1·0% (0·7–1·6) 74·5% (65·3–83·5) 1·6% (0·5–3·7)
Suriname 67·6% 15·5% 15·2% 1·7% 68·6% (56·5–78·3) 16·4% (11·1–23·5) 14·9% (9·3–22·2) 0·1% (0·0–1·7)
Swaziland 66·6% 8·4% 10% 15% 70·3% (55·0–82·3) 6·5% (4·2–9·6) 8·1% (5·1–12·2) 15·1% (5·3–31·1)
Sweden 85·1% 0·6% 14·2% 0% 86·8% (82·5–89·7) 0·6% (0·4–1·0) 12·6% (9·8–16·8) 0·0% (0·0–0·0)
Switzerland 60·3% 15·2% 24·5% 0% 66·2% (60·4–70·7) 10·3% (8·8–12·1) 23·5% (20·0–28·7) 0·0% (0·0–0·0)
Syria 44·5% 3·3% 51·6% 0·6% 52·3% (40·4–67·0) 3·3% (2·1–4·9) 43·8% (29·8–55·7) 0·6% (0·1–1·4)
Tajikistan 22·9% 8·7% 57·9% 10·6% 39·6% (29·1–53·3) 5·0% (2·9–9·9) 47·9% (36·7–57·7) 7·5% (2·4–16·6)
Tanzania 20·3% 17·1% 20·2% 42·4% 34·0% (20·7–53·1) 23·3% (14·9–32·0) 20·1% (12·6–28·5) 22·7% (8·5–43·0)
Thailand 78·7% 8·6% 12·1% 0·7% 82·1% (75·8–88·2) 8·8% (5·7–13·0) 9·1% (5·1–13·2) 0·0% (0·0–0·0)
The Bahamas 45·9% 24·9% 29·2% 0% 49·7% (41·1–60·6) 23·4% (17·8–29·5) 26·8% (19·9–35·3) 0·0% (0·0–0·0)
The Gambia 47·4% 0% 13·6% 39% 46·2% (26·2–64·0) 0·5% (0·3–0·9) 12·0% (6·7–18·3) 41·4% (19·7–66·3)
Timor-Leste 51·6% 0% 7·4% 41% 58·5% (27·0–82·7) 1·6% (0·8–2·9) 5·4% (2·2–11·5) 34·5% (11·7–66·4)
Togo 29·7% 7·8% 44·3% 18·3% 41·5% (29·9–55·9) 7·0% (5·1–9·2) 39·0% (28·5–48·5) 12·5% (4·4–26·2)
(Table 2 continues on next page)
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frontier. Across regions, countries in sub-Saharan Africa 
would expand health spending the most, with an 82·8% 
(UI 35·7–121·1) increase, followed by south Asia 
(71·7%, 0·1–155·3) and north Africa and the Middle East 
(35·7%, 7·2–65·8).
Figure 4 shows policy counterfactuals for the six most 
populous low-income and lower-middle-income countries 
and table 3 (columns 4 through 7) lists country-specific 
results. In this figure and table, the effects of three 
scenarios are shown: government spending increases (ie, 
increasing all-sector government spending to meet the 
frontier determined by GDP); reprioritisation of health in 
the government budget (ie, increasing government health 
spending to the frontier determined by all-sector 
government spending); and both government spending 
increases and reprioritisation of health in the government 
budget. In figure 4, the vertical distance between the three 
counterfactuals and the starting position (in black) 
illustrates the potential gains. The magnitude of the 
increases resulting from the policy changes vary 
depending on the country context. For instance, in 
Bangladesh, Nigeria, and Philippines, increases in all-
sector government spending results in more government 
health spending rather than an increase in the share of the 
all-sector government budget that is devoted to health. By 
contrast, in India and Pakistan, increases in the share of 
the all-sector government budget that is devoted to health 
increases government health spending more than 
increases in all-sector government spending.
The implications of the policy changes for government 
health spending per capita vary across income groupings 
and region. For low-income countries, raising of 
government spending would increase government 
health spending per capita by $68 (UI 10–161), whereas 
reprioritisation of health would augment government 
health spending per capita by $107 (73–148). Government 
spending increases translate into $408 (UI 35–966) 
per capita in lower-middle-income countries and $569 
(0–4585) per capita in upper-middle-income countries. 
Reprioritisation of health would, by contrast, augment 
government health spending per capita by $525 
(UI 349–697) in lower-middle-income countries and 
$3145 (761–5392) in upper-middle-income countries. 
Overall, in low-income and middle-income countries, 
more government health spending per capita is 
increased by reprioritisation of health in the government 
budget, rather than the raising of more government 
resources, although table 3 shows enormous country 
level variation. By contrast, sub-Saharan Africa stands 
out; increases in the amount of government spending to 
the frontier would lead to more health resources rather 
than an increase in the allocation of government 
spending on health.
Figure 5 highlights the range of potential increases in 
government health spending as a proportion of GDP for 
low-income and middle-income countries. Countries 
with the highest potential increases are predominantly in 
Africa, the Middle East, and southeast Asia.
2014 2040
Government 
spending as 
share of total (%)
Prepaid private 
spending as 
share of total (%)
Out-of-pocket 
spending as 
share of total (%)
Development 
assistance for 
health as share 
of total (%)
Government 
spending as share 
of total (%)
Prepaid private 
spending as share 
of total (%)
Out-of-pocket 
spending as share 
of total (%)
Development 
assistance for health 
as share of total (%)
(Continued from previous page)
Tonga 69·5% 0·4% 11·7% 18·5% 75·7% (57·5–89·0) 0·8% (0·4–1·4) 8·2% (4·3–12·5) 15·3% (4·5–33·8)
Trinidad and Tobago 54·5% 6·8% 38·7% 0% 56·3% (46·9–66·8) 7·1% (5·0–9·7) 36·7% (27·1–46·5) 0·0% (0·0–0·0)
Tunisia 57·2% 4·5% 38·1% 0·2% 60·7% (53·6–67·4) 4·4% (3·5–6·1) 34·8% (28·6–41·6) 0·1% (0·0–0·3)
Turkey 78·4% 3·5% 18% 0·1% 79·5% (75·3–84·4) 3·0% (2·2–3·6) 17·5% (13·2–21·5) 0·0% (0·0–0·0)
Turkmenistan 59·2% 8·7% 31·6% 0·6% 67·6% (57·4–76·8) 6·1% (4·3–8·3) 26·2% (18·5–35·2) 0·0% (0·0–0·0)
Uganda 0·9% 64·8% 16·4% 18% 3·7% (1·3–8·0) 52·5% (40·1–62·3) 25·1% (18·7–31·4) 18·7% (7·2–35·8)
Ukraine 51·3% 0·9% 46·8% 0·9% 48·1% (34·8–56·8) 1·0% (0·7–1·7) 49·0% (40·4–62·3) 2·0% (0·2–7·0)
United Arab Emirates 72·3% 9·9% 17·8% 0% 75·7% (66·9–84·9) 9·0% (5·4–13·5) 15·3% (9·1–22·7) 0·0% (0·0–0·0)
UK 83·1% 7·1% 9·7% 0% 83·3% (79·3–86·9) 7·1% (5·6–8·9) 9·5% (7·3–12·6) 0·0% (0·0–0·0)
USA 49·8% 38·8% 11·4% 0% 51·9% (46·2–57·4) 37·8% (33·2–43·2) 10·2% (8·7–11·9) 0·0% (0·0–0·0)
Uruguay 71·2% 13·2% 15·6% 0% 74·2% (67·0–79·6) 12·7% (9·8–17·2) 13·1% (9·3–17·7) 0·0% (0·0–0·0)
Uzbekistan 51·9% 2·6% 43·7% 1·7% 69·3% (57·6–80·6) 1·6% (1·0–2·2) 28·5% (17·7–39·6) 0·6% (0·0–1·7)
Vanuatu 56·7% 0% 5·4% 37·9% 69·0% (43·2–88·4) 0·7% (0·3–1·3) 3·6% (1·7–6·0) 26·7% (8·2–53·2)
Venezuela 29·3% 6·3% 64·3% 0% 35·7% (26·0–46·0) 6·4% (4·8–8·8) 58·0% (48·4–67·0) 0·0% (0·0–0·0)
Vietnam 53% 6·9% 37·4% 2·7% 66·9% (54·5–77·9) 5·7% (4·1–7·8) 27·1% (17·0–38·5) 0·4% (0·0–1·8)
Yemen 14·3% 1·7% 74·7% 9·3% 13·5% (3·9–27·7) 1·4% (0·9–2·2) 67·8% (48·0–83·9) 17·3% (5·2–39·0)
Zambia 32·6% 0% 27·7% 39·7% 44·7% (29·2–59·8) 1·1% (0·7–1·7) 27·2% (17·8–37·6) 26·9% (10·6–49·2)
Data in parentheses are uncertainty intervals. Data are percentages. GBD=global burden of disease.
Table 2: Expected health spending by source in 2040
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Figure 6 shows the difference between expected and 
potential government spending for each global burden 
of disease super region. The gain is shown in each 
region from the generation of more government 
spending and reprioritisation of the health sector, to the 
extent indicated by the frontier. In each region, these 
policy changes would lead to more government 
spending per capita on health and government health 
expenditure constituting a much higher share of total 
health expenditure. In per capita terms, southeast Asia, 
east Asia, and Oceania would increase government 
health spending per capita the most by reaching the 
potential levels. South Asia could potentially make the 
biggest increase in the share of total spending that is 
from the government.
Discussion
With GDP, all-sector government spending, and health 
spending forecast estimates as well as frontier analysis, 
we assessed alternative scenarios illustrating potential 
increase in funds for health. We find that future, expected 
health spending varies substantially across countries. 
However, increases in total and government health 
spending are expected for nearly all countries.
This study highlights the multifaceted role economic 
development has in the trajectory of health financing. 
Economic growth leads to more spending across sectors 
as well as on health. Our analysis emphasises that in 
most countries, and especially China, expected economic 
growth is likely to catalyse more health spending.
Although economic growth is clearly a major driver of 
health spending, it is not deterministic. We find that a 
great deal of variation remains for countries at similar 
levels of economic development. The USA and the 
United Arab Emirates, for instance, which are expected to 
have similar GDP per capita in 2040, spend very different 
amounts on health. The USA is expected to spend 18·5% 
(UI 16·5–20·7) of GDP on health by 2040, whereas the 
United Arab Emirates is estimated to spend just 4·6% 
(3·5–6·8) by that time. This finding is true at lower levels 
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Figure 3: Expected health spending frontiers in 2040
Per capita spending is measured in 2015 PPP US$. The fitted lines are the estimated spending frontier. GDP=gross domestic product. PPP$=purchasing power parity US$.
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Total health spending per capita in 2040 ($) Government health spending per capita in 2040 ($)
Expected Potential Expected Potential government 
spending based on 
increasing all-sector 
government revenue
Potential government 
spending based on 
health sector 
prioritisation
Potential government 
spending based on 
increasing all-sector 
government revenue and 
health sector prioritisation
Income level
Upper-middle 
income
3903 (2770–5741) 4638 (3130–6180) 2812 (1755–4635) 3643 (2055–7195) 5955 (4483–7746) 7406 (5043–10 275)
Lower-middle 
income
844 (739–1004) 1525 (1108–1942) 387 (289–545) 826 (440–1328) 913 (779–1061) 1837 (1131–2539)
Low income 195 (157–258) 321 (255–394) 57 (45–76) 121 (69–198) 161 (132–194) 285 (183–385)
Region
Central Europe, 
eastern Europe, 
and central Asia
2417 (2252–2637) 2511 (2121–2999) 1511 (1377–1671) 1798 (1301–2389) 2370 (1874–2866) 3399 (2464–4373)
Latin America 
and Caribbean
2047 (1720–2494) 2297 (1964–2699) 1226 (915–1661) 1661 (1220–2224) 2298 (1760–2894) 2933 (2170–3695)
North Africa 
and Middle East
1630 (1431–1975) 1837 (1470–2153) 1045 (856–1387) 1261 (839–1821) 1753 (1495–2075) 2512 (1864–3192)
South Asia 935 (773–1203) 1599 (973–2244) 413 (260–673) 812 (317–1693) 1021 (829–1248) 1916 (1048–2985)
Southeast Asia, 
east Asia, 
and Oceania
4035 (2640–6314) 5080 (3064–7000) 2997 (1711–5223) 3980 (2023–8524) 6382 (4542–8659) 8255 (5310–11 921)
Sub-Saharan Africa 307 (269–365) 557 (435–656) 119 (102–142) 272 (151–444) 271 (222–335) 556 (356–737)
Country
Afghanistan 249 (179–388) 272 (249–405) 49 (25–142) 58 (49–184) 213 (170–262) 237 (175–351)
Albania 1733 (1404–2144) 2292 (1733–3129) 1013 (732–1406) 1684 (1013–3152) 1809 (1280–2434) 2913 (1624–4449)
Algeria 2080 (1439–3337) 2114 (2080–3316) 1696 (1061–2954) 1752 (1696–3065) 2951 (1696–4187) 3005 (1858–4189)
Andorra 308 (154–414) 1190 (595–1893) 198 (56–291) 506 (198–1670) 745 (198–1822) 1379 (558–2439)
Argentina 3012 (2202–4807) 4020 (3012–6243) 1999 (1274–3799) 2144 (1999–4787) 6906 (4356–9293) 7202 (4808–10088)
Armenia 997 (727–1578) 1718 (1128–2367) 539 (337–1106) 981 (539–2283) 1203 (661–1926) 2057 (1177–3137)
Azerbaijan 2502 (2033–3062) 3308 (2502–4978) 671 (424–1141) 1433 (671–3408) 2263 (1357–3466) 4505 (2338–7650)
Bangladesh 266 (206–327) 919 (531–1330) 81 (53–128) 365 (122–780) 224 (160–308) 965 (429–1569)
Belarus 2369 (1648–3243) 2802 (2369–3845) 1634 (952–2496) 5473 (2214–10 802) 1649 (1634–2507) 5496 (2390–10 802)
Belize 844 (703–1017) 1212 (844–1645) 578 (443–747) 834 (578–1391) 965 (711–1264) 1361 (862–2049)
Benin 232 (161–357) 352 (232–477) 133 (75–250) 167 (133–349) 276 (163–448) 326 (195–476)
Bhutan 940 (517–1558) 2379 (1364–3313) 728 (320–1349) 1420 (728–3316) 1826 (810–3360) 3078 (1541–4702)
Bolivia 943 (736–1252) 1126 (943–1596) 734 (533–1038) 962 (734–1836) 983 (734–1360) 1266 (773–1961)
Bosnia and 
Herzegovina
2613 (1921–3416) 2613 (2613–3376) 2069 (1407–2847) 2362 (2069–4442) 2467 (2069–3005) 2782 (2069–4525)
Botswana 1878 (1452–2524) 2420 (1878–3756) 1152 (777–1780) 1677 (1152–3860) 2253 (1513–3184) 3145 (1923–5459)
Brazil 2770 (2150–3708) 2771 (2770–3774) 1572 (994–2509) 1644 (1572–2850) 3551 (2066–5144) 3660 (2306–5211)
Bulgaria 3870 (2896–5754) 3895 (3870–5805) 2412 (1516–4264) 2789 (2412–5934) 4102 (2762–5681) 4577 (3144–6558)
Burkina Faso 128 (101–168) 281 (178–393) 52 (37–62) 100 (52–189) 125 (70–202) 232 (121–367)
Burundi 104 (65–176) 127 (104–188) 36 (19–56) 53 (36–109) 64 (36–101) 90 (51–147)
Cambodia 642 (543–760) 1026 (642–1458) 162 (86–250) 367 (162–773) 522 (297–806) 1100 (551–1695)
Cameroon 190 (150–238) 469 (328–609) 48 (30–82) 98 (48–193) 218 (140–309) 428 (237–609)
Cape Verde 768 (523–1124) 1421 (902–1991) 532 (294–874) 1046 (532–2177) 895 (532–1461) 1642 (879–2554)
Central African 
Republic
58 (25–145) 64 (58–151) 5 (2–6) 21 (6–56) 9 (5–17) 34 (16–82)
Chad 138 (75–212) 358 (218–548) 74 (16–142) 183 (74–535) 155 (74–329) 321 (150–618)
China 5703 (3571–9218) 6658 (5703–9661) 4326 (2357–7776) 5429 (4326–12550) 9191 (6338–12763) 11233 (6662–16 657)
Colombia 2398 (1616–3727) 2555 (2398–3708) 1888 (1107–3215) 2573 (1888–5485) 2512 (1888–3379) 3316 (2108–5490)
Comoros 132 (96–184) 160 (132–214) 35 (19–65) 53 (35–121) 79 (45–126) 118 (67–176)
(Table 3 continues on next page)
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Total health spending per capita in 2040 ($) Government health spending per capita in 2040 ($)
Expected Potential Expected Potential government 
spending based on 
increasing all-sector 
government revenue
Potential government 
spending based on 
health sector 
prioritisation
Potential government 
spending based on 
increasing all-sector 
government revenue and 
health sector prioritisation
(Continued from previous page)
Congo (Brazzaville) 544 (394–736) 768 (544–1097) 461 (316–651) 658 (461–1397) 655 (461–1114) 871 (461–1433)
Costa Rica 3050 (2207–4077) 3087 (3050–4049) 2261 (1437–3273) 3393 (2261–6331) 2651 (2261–3468) 3885 (2338–6331)
Côte d’Ivoire 292 (246–352) 542 (367–736) 90 (63–132) 227 (100–449) 210 (130–316) 509 (274–773)
Cuba 3097 (2091–4454) 3113 (3097–4468) 2961 (1955–4323) 3063 (2961–4822) 3371 (2961–4284) 3470 (2961–4822)
DR Congo 83 (56–123) 176 (90–276) 28 (16–53) 42 (28–108) 106 (43–202) 141 (70–235)
Djibouti 842 (598–1324) 846 (842–1324) 579 (358–1057) 586 (579–1062) 811 (579–1119) 817 (579–1119)
Dominica 1092 (874–1406) 1533 (1092–2056) 802 (605–1106) 928 (802–1604) 1733 (1122–2473) 1945 (1283–2729)
Dominican Republic 1833 (1316–2498) 3071 (1877–4419) 1367 (861–2019) 3766 (1367–8015) 1651 (1367–2471) 4354 (2049–8015)
Ecuador 1935 (1534–2410) 1937 (1935–2403) 1035 (697–1466) 1416 (1035–2645) 1488 (1035–2078) 1966 (1231–2987)
Egypt 1212 (1070–1453) 1966 (1270–2607) 481 (384–708) 930 (481–1697) 1291 (821–1866) 2408 (1353–3493)
El Salvador 1520 (1089–2337) 1673 (1520–2292) 1136 (743–1953) 1136 (1136–1868) 3541 (2905–4166) 3541 (2905–4166)
Equatorial Guinea 1746 (1302–2291) 3905 (2057–7064) 1350 (927–1872) 2232 (1350–5465) 3964 (1545–7506) 5826 (2727–10 675)
Eritrea 84 (56–129) 190 (126–264) 22 (11–36) 30 (22–68) 121 (60–195) 152 (88–230)
Ethiopia 212 (153–311) 476 (241–843) 81 (59–113) 281 (85–691) 141 (81–262) 446 (164–913)
Federated States 
of Micronesia
767 (302–1703) 772 (767–1643) 53 (27–86) 58 (53–114) 404 (291–537) 431 (299–593)
Fiji 705 (630–804) 1399 (947–1901) 452 (401–525) 729 (452–1189) 1015 (712–1416) 1604 (965–2369)
Gabon 1336 (966–1900) 2075 (1344–2884) 1088 (723–1643) 1466 (1088–2956) 2099 (1220–3269) 2689 (1640–4001)
Georgia 1608 (1268–1972) 1694 (1608–2263) 380 (243–657) 718 (380–1709) 1069 (645–1673) 1893 (1042–2993)
Ghana 288 (214–381) 765 (451–1107) 178 (110–264) 330 (178–746) 465 (217–794) 783 (401–1279)
Grenada 1412 (1157–1755) 1928 (1412–2806) 729 (550–1051) 928 (729–1805) 1970 (1273–2837) 2447 (1548–3823)
Guatemala 715 (622–808) 1089 (734–1424) 275 (205–354) 747 (338–1306) 444 (323–607) 1182 (648–1702)
Guinea 165 (114–243) 214 (165–283) 66 (33–115) 101 (66–210) 119 (66–203) 170 (97–259)
Guinea-Bissau 115 (74–194) 221 (140–318) 3 (2–8) 18 (5–54) 42 (14–95) 173 (84–284)
Guyana 903 (733–1142) 1381 (931–1828) 523 (380–741) 877 (523–1625) 983 (598–1449) 1583 (925–2314)
Haiti 250 (178–385) 294 (250–410) 3 (1–7) 4 (3–14) 156 (120–199) 241 (141–362)
Honduras 716 (625–887) 800 (716–1074) 366 (302–529) 587 (366–1122) 516 (370–692) 805 (475–1243)
India 1138 (927–1488) 1822 (1138–2666) 505 (307–848) 959 (505–2112) 1234 (994–1518) 2226 (1135–3615)
Indonesia 793 (640–986) 2524 (1483–3592) 382 (252–565) 1216 (433–2529) 1078 (739–1491) 3259 (1561–5182)
Iran 2051 (1489–2709) 2341 (2051–3318) 980 (498–1554) 3011 (980–6876) 1125 (980–1669) 3319 (1516–6876)
Iraq 1230 (860–1897) 1740 (1230–2654) 783 (424–1444) 862 (783–1751) 2413 (1047–4132) 2598 (1409–4143)
Jamaica 1000 (748–1399) 1217 (1000–1759) 634 (386–1034) 813 (634–1713) 1130 (701–1617) 1416 (879–2165)
Jordan 1335 (1144–1565) 1632 (1335–2450) 901 (740–1118) 1426 (901–2576) 1266 (901–1893) 1930 (1152–3286)
Kazakhstan 2047 (1787–2500) 3972 (2466–5564) 1138 (896–1587) 3326 (1508–6221) 2010 (1296–2945) 5627 (2938–8574)
Kenya 286 (209–423) 490 (329–636) 112 (83–213) 195 (112–404) 266 (184–387) 452 (258–657)
Kyrgyzstan 384 (302–492) 514 (384–738) 202 (143–291) 409 (202–887) 262 (202–422) 502 (242–900)
Laos 285 (178–419) 1793 (908–2675) 127 (65–230) 267 (127–672) 1111 (705–1617) 2159 (1022–3587)
Lebanon 1895 (1458–2499) 2559 (1895–4858) 968 (603–1549) 2481 (968–6948) 1467 (968–2684) 3426 (1476–8244)
Lesotho 726 (464–1010) 729 (726–1003) 516 (294–757) 523 (516–773) 755 (523–987) 760 (527–987)
Liberia 276 (224–373) 277 (276–377) 5 (1–18) 8 (5–32) 81 (29–150) 112 (55–185)
Libya 979 (590–1637) 1142 (979–2158) 811 (441–1470) 868 (811–1962) 1875 (1256–2453) 1976 (1260–2949)
Macedonia 1742 (1549–1931) 2234 (1742–3016) 1080 (954–1211) 1895 (1080–2951) 1630 (1161–2328) 2803 (1652–4112)
Madagascar 73 (56–106) 193 (121–285) 28 (24–33) 144 (60–291) 32 (28–49) 160 (72–295)
Malawi 219 (160–320) 223 (219–327) 100 (77–135) 136 (100–260) 119 (100–181) 157 (100–262)
Malaysia 2528 (2099–3249) 5014 (3226–6840) 1428 (1126–2117) 2281 (1428–4204) 4856 (3393–6525) 7506 (4449–11 002)
Maldives 6070 (3725–9978) 6095 (6070–9722) 4823 (2464–8764) 4996 (4823–9589) 6896 (4823–9314) 7072 (4823–9811)
(Table 3 continues on next page)
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Total health spending per capita in 2040 ($) Government health spending per capita in 2040 ($)
Expected Potential Expected Potential government 
spending based on 
increasing all-sector 
government revenue
Potential government 
spending based on 
health sector 
prioritisation
Potential government 
spending based on 
increasing all-sector 
government revenue and 
health sector prioritisation
(Continued from previous page)
Mali 300 (231–402) 409 (300–554) 112 (67–191) 154 (112–321) 287 (167–426) 376 (203–560)
Marshall Islands 785 (448–1130) 788 (785–1111) 502 (228–729) 1293 (502–2853) 504 (502–729) 1294 (502–2853)
Mauritania 258 (193–366) 602 (378–820) 140 (89–244) 175 (140–376) 516 (271–801) 621 (360–885)
Mauritius 3459 (2435–5042) 4438 (3459–6149) 2308 (1365–3890) 4450 (2308–9867) 3498 (2714–4538) 6485 (3433–10 491)
Mexico 1726 (1403–2084) 2178 (1726–2889) 962 (672–1253) 1526 (962–2585) 1752 (1467–2084) 2714 (1695–3940)
Moldova 910 (755–1122) 928 (910–1220) 429 (332–579) 655 (429–1222) 596 (429–887) 881 (515–1432)
Mongolia 1685 (1177–2462) 2982 (1685–4412) 981 (566–1731) 1565 (981–3579) 2841 (1304–4932) 4136 (2112–6479)
Montenegro 2189 (1734–3138) 2394 (2189–3258) 1376 (942–2314) 1823 (1376–3803) 2348 (1879–2842) 3043 (2118–4445)
Morocco 1056 (945–1160) 1708 (1083–2472) 322 (248–382) 547 (322–968) 1241 (862–1692) 2050 (1140–3174)
Mozambique 117 (59–222) 267 (141–384) 18 (7–43) 20 (18–51) 257 (135–392) 274 (155–401)
Myanmar 979 (476–2210) 1987 (979–3099) 752 (269–2005) 1074 (752–3391) 1995 (1266–2630) 2597 (1400–4288)
Namibia 1929 (1590–2499) 1955 (1929–2563) 1200 (913–1752) 1308 (1200–2257) 2234 (1565–2902) 2392 (1635–3279)
Nepal 321 (263–388) 592 (383–840) 119 (93–160) 268 (120–517) 267 (152–438) 568 (295–914)
Nicaragua 830 (618–1005) 883 (830–1136) 459 (265–600) 1158 (495–2085) 468 (459–611) 1170 (532–2085)
Niger 98 (73–139) 159 (104–226) 40 (23–75) 40 (40–76) 162 (117–210) 163 (120–212)
Nigeria 343 (268–449) 877 (538–1202) 86 (36–177) 477 (113–1245) 204 (86–469) 921 (453–1441)
Pakistan 296 (237–383) 897 (579–1146) 142 (95–227) 330 (142–641) 429 (241–698) 934 (516–1324)
Panama 4569 (3750–5565) 4857 (4569–6570) 3432 (2676–4386) 5369 (3432–10 023) 4471 (3432–6044) 6806 (3664–10 906)
Papua New Guinea 224 (167–304) 465 (307–707) 166 (120–235) 236 (166–492) 312 (210–421) 432 (263–713)
Paraguay 1916 (1460–2827) 1916 (1916–2741) 1067 (665–1979) 1250 (1067–2870) 1696 (1067–2358) 1948 (1197–3121)
Peru 1276 (1032–1692) 2057 (1291–2807) 848 (635–1253) 2066 (880–3965) 1079 (848–1416) 2573 (1268–4033)
Philippines 787 (661–920) 1335 (866–1930) 340 (226–454) 979 (432–1864) 540 (401–705) 1514 (799–2396)
Romania 3500 (2608–4864) 3868 (3500–5144) 3041 (2162–4400) 4656 (3041–8158) 3655 (3041–5076) 5491 (3233–8320)
Russia 2665 (2416–3206) 3013 (2665–4031) 1413 (1281–1635) 1787 (1413–2841) 3268 (2198–4350) 4064 (2704–5923)
Rwanda 278 (188–448) 364 (278–545) 4 (1–13) 7 (4–25) 219 (130–345) 320 (177–518)
Saint Lucia 1340 (1086–1782) 1666 (1340–2423) 798 (574–1237) 821 (798–1404) 2537 (1790–3379) 2586 (1809–3419)
Saint Vincent 
and the Grenadines
1506 (1106–2137) 1568 (1506–2142) 784 (442–1393) 1038 (784–2218) 1397 (888–2027) 1805 (1133–2683)
Samoa 555 (403–856) 766 (555–1077) 474 (333–775) 616 (474–1243) 656 (474–966) 823 (495–1279)
São Tomé and 
Príncipe
397 (262–608) 474 (397–648) 184 (113–281) 328 (184–720) 279 (184–516) 456 (233–732)
Senegal 182 (140–245) 345 (227–456) 85 (63–127) 134 (85–255) 194 (139–266) 298 (169–446)
Serbia 2319 (2113–2616) 2320 (2319–2618) 1434 (1287–1608) 1542 (1434–2096) 2416 (1998–2834) 2587 (2120–3411)
Sierra Leone 290 (227–423) 291 (290–419) 21 (12–34) 62 (21–167) 65 (26–134) 165 (50–322)
Solomon Islands 141 (82–230) 291 (176–419) 78 (41–131) 81 (78–139) 310 (208–426) 317 (213–427)
Somalia 42 (27–72) 74 (43–107) 10 (6–13) 37 (11–69) 13 (10–18) 47 (19–80)
South Africa 1815 (1555–2165) 1821 (1815–2174) 981 (751–1315) 1289 (981–2192) 1489 (1204–1794) 1930 (1340–2737)
South Sudan 145 (78–283) 256 (182–336) 41 (15–113) 41 (41–114) 291 (172–545) 298 (179–545)
Sri Lanka 1645 (1207–2289) 3323 (1964–4684) 1048 (617–1693) 3100 (1056–6644) 1664 (1048–2575) 4574 (2237–7322)
Sudan 594 (478–730) 741 (594–1017) 136 (81–198) 653 (192–1409) 179 (136–309) 790 (353–1409)
Suriname 1195 (856–1630) 2430 (1635–3257) 828 (500–1253) 2099 (828–5089) 1463 (828–2989) 3231 (1788–5337)
Swaziland 1467 (1062–2094) 1467 (1467–2111) 1036 (699–1614) 1119 (1036–2006) 1321 (1036–1815) 1411 (1036–2056)
Syria 926 (703–1274) 2077 (1242–2971) 492 (327–814) 747 (492–1698) 1852 (1060–2902) 2639 (1434–4162)
Tajikistan 398 (324–509) 439 (398–594) 160 (102–264) 232 (160–482) 283 (168–429) 395 (223–603)
Tanzania 308 (225–445) 507 (308–714) 106 (62–213) 200 (106–462) 271 (147–455) 474 (237–743)
Thailand 1689 (1315–2326) 3086 (2004–4388) 1392 (1023–2031) 2080 (1392–4139) 2910 (2187–3741) 4190 (2608–6445)
(Table 3 continues on next page)
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of income as well: Namibia expected to spend 10·2% (UI 
8·4–13·2) of GDP on health in 2040, and India, estimated 
to spend 5·6% (4·6–7·3) of GDP on health in 2040, are 
expected to have similar GDP per capita in 2040. Overall, 
our 2040 health spending per capita estimates range 
from $42 to $15 026, and from 1·4% of GDP to 22·2%.
Based on our potential spending estimates, most 
governments in low-income and middle-income countries 
could spend more on health in 2040 than in 2014 if they 
increased spending levels to reach the spending frontier, 
although the best strategy for increasing government 
spending depends on the country. In some countries, 
such as Bangladesh, Nigeria, and the Philippines, 
generation of more all-sector government spending would 
lead to the largest increase in government spending on 
health. For example, in 2014, government health spending 
per capita in Bangladesh was $21. In 2040, this figure is 
expected to be $81 (UI 53–128). This amount is nonetheless 
below the $86 per capita estimated in 2012 purchasing 
power parity dollars to be a minimum required to provide 
universal primary health-care services.38 However, we 
estimate that if the government could generate more all-
sector government spending at the frontier, as determined 
by their level of development, there would be an 
additional $254 (UI  32–710) available per capita to spend 
towards meeting health sector goals. Mechanisms for 
increasing government spending revolve often around tax 
policy and the enforcement of tax policy. In other 
countries, such as India and Pakistan, reprioritisation of 
government spending towards the health sector is key. In 
Pakistan, for instance, government spending on health 
per capita was $42 in 2014. Government spending per 
capita is expected to increase to $142 (UI 95–227) in 2040. 
With reprioritisation of government spending on health, 
an additional $267 (UI 82–558) could be spent per capita 
on health. Implementation of both policy options would 
naturally lead to more spending on health.
However, the ability to reach spending frontiers and 
realise potential spending is more within reach for some 
countries than others. Contextual features such as 
national debt, corruption, or a substantive portion of the 
economy being informal (meaning it is not taxed or 
monitored by the government) might be distinct 
challenges for some countries, and might make reaching 
the spending frontier difficult. Prospective, country-
specific, fiscal space analyses are needed to provide 
countries with tailored, country-specific capacity to spend 
assessments.
This study also shows that the differences in spending 
across countries, and across income groups in particular, 
are expected to persist. In some cases, in fact, we expect 
that without proactive policy changes, these differences 
will widen over time. Furthermore, our mean development 
assistance for health estimates suggest that development 
assistance for health will only marginally increase by 2040. 
The weak growth of health spending in the future in some 
countries is a result of the expected tepid growth in 
development assistance for health, and underlines the 
important part that development assistance for health 
continues to play in supporting health and health systems 
in low-income and middle-income countries.14 An 
important factor related to this difference is how health 
Total health spending per capita in 2040 ($) Government health spending per capita in 2040 ($)
Expected Potential Expected Potential government 
spending based on 
increasing all-sector 
government revenue
Potential government 
spending based on 
health sector 
prioritisation
Potential government 
spending based on 
increasing all-sector 
government revenue and 
health sector prioritisation
(Continued from previous page)
The Gambia 199 (134–326) 212 (199–315) 88 (68–118) 156 (88–292) 99 (88–152) 171 (91–292)
Togo 142 (113–187) 252 (162–358) 60 (38–99) 91 (60–192) 147 (72–244) 208 (115–316)
Tonga 553 (352–954) 740 (553–1027) 424 (244–814) 474 (424–973) 788 (424–1186) 854 (528–1219)
Tunisia 1390 (1195–1653) 1713 (1390–2380) 847 (672–1085) 1427 (847–2530) 1239 (960–1539) 2034 (1223–3157)
Turkey 2441 (2096–3065) 3421 (2441–4850) 1946 (1613–2570) 2103 (1946–3513) 4936 (3814–6212) 5322 (3921–7459)
Turkmenistan 1638 (1237–2191) 4423 (2345–7144) 1117 (730–1668) 2674 (1117–6216) 2927 (1491–4977) 6439 (2886–11 326)
Uganda 384 (307–489) 392 (384–506) 14 (5–31) 41 (14–116) 113 (68–169) 309 (148–496)
Ukraine 715 (557–899) 910 (715–1376) 343 (232–413) 625 (343–1221) 547 (354–814) 954 (517–1642)
Uzbekistan 1299 (931–1894) 1448 (1299–2093) 912 (564–1496) 945 (912–1712) 2017 (1191–2802) 2091 (1303–2902)
Vanuatu 283 (162–524) 348 (283–546) 197 (106–426) 287 (197–749) 236 (197–430) 335 (197–749)
Venezuela 1285 (1082–1528) 1931 (1285–2976) 463 (295–677) 1000 (463–2250) 1197 (626–1994) 2376 (1162–4193)
Vietnam 1545 (1121–2038) 1794 (1545–2466) 1040 (660–1509) 2078 (1040–4032) 1166 (1040–1599) 2279 (1113–4032)
Yemen 276 (197–400) 404 (276–548) 37 (10–85) 85 (37–228) 166 (107–239) 357 (192–538)
Zambia 345 (251–497) 622 (377–820) 153 (108–224) 319 (153–618) 309 (179–519) 604 (316–877)
Data in parentheses are uncertainty intervals. Data are 2015 purchasing power parity US$. 
Table 3: Potential total and government health spending for low-income and middle-income countries in 2040
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Figure 4: Potential government health spending of the six most populated low-income and lower-middle-income countries in 2040
Per capita spending is measured in 2015 PPP US$. The grey fitted lines are the estimated government health spending frontier. The short red lines parallel to the 
frontier represents the increases possible simply by raising more government spending. The vertical distance between the black and coloured lines represents 
potential increases in government health spending. 
Articles
2026 www.thelancet.com   Vol 389   May 20, 2017
spending is distributed within each country. We report per 
capita health spending in this paper, which excludes 
within-country inequalities. As health spending in most 
countries is unequal, and most of the world’s poor now 
live in middle-income countries, understanding how 
development assistance for health can target those most 
in need will be increasingly important.
The Sustainable Development Goals (SDGs) include a 
subgoal on health financing that aims to “substantially 
increase health financing…especially in least developed 
countries and small island developing States.”39 
Additionally, the Addis Ababa Action Agenda of 2015 has 
already made the case for increasing domestic funding for 
health by re-envisioning such commitments as investment 
cases and introducing innovative financing mechanisms, 
including private funding and external support.40
In addition to planning for the SDGs, an understanding 
of future health spending is important in the context of 
the ongoing epidemiological transition occurring in 
many middle-income (and some low-income) countries. 
As countries’ health burdens transition from infectious 
and childhood diseases to chronic, non-communicable 
diseases, different health system tools are needed. In 
some cases, these tools are expensive and require 
different health system infrastructure. As these health 
system demands are anticipated, health financing experts 
must develop plans rooted in medium-term and long-
term forecasts, and consider a diverse set of policy 
options for raising the necessary resources.
An important point of caution is that this study does not 
assess the necessary amount of spending, and whether 
resources are spent efficiently and equitably. More 
spending does not necessarily guarantee better population 
health outcomes, and certainly does not secure more 
equitable distribution of health outcomes. Indeed, in most 
high-income countries, health policy spending targets 
revolve around the reduction of spending and strategies to 
increase efficiency. Health spending forecasts are valuable 
in high-income countries as a note of caution, because 
they reflect high levels of expected future spending based 
on past trends and relationships. However, our frontier 
analyses were designed to motivate governments and 
other development assistance partners to look at how 
countries compare, and to assess the strategies best suited 
to increase funding in low-income and middle-income 
countries. It is just as vital to understand how and where 
increased health spending is used, in addition to how it 
was mobilised. Improvement in the tracking of health 
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Figure 5: Potential increase in government health spending in 2040
The potential increase is the ratio of potential government health spending over expected government health spending, where potential spending is based on generating all-sector government 
spending and prioritising health sector at the level indicated by each frontier, based on each country’s gross domestic product per capita in 2040. High-income countries and Zimbabwe are grey 
because we did not complete the potential spend counterfactual for these countries. ATG=Antigua and Barbuda. FSM=Federated States of Micronesia. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad 
and Tobago. VCT=Saint Vincent and the Grenadines.
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resources is an important complement to our analysis of 
the future of global health financing.
Estimation of future spending is inherently uncertain. 
Health spending is a complicated product of national, 
international, and subnational policy decision making, 
institutional factors, the supply and demand of the health 
system, economic development, and even war, civil strife, 
natural disaster, and other environmental issues 
potentially related to climate change. Many of these factors 
are not forecasted through 2040. To make credible health 
spending estimates through 2040, we rely on past global 
and country specific spending trends and the relationships 
between these variables and economic development, 
government spending, and demographic variables. 
Because these methods and forecasting in general are far 
from exact, we quantified uncertainty by propagating UIs 
that increased the further we projected into the future. 
These intervals propagate data, model, and parameter 
uncertainty, and should be interpreted as plausible ranges, 
as established by past trends and relationships. Although 
the mean projection marks our point estimate, the large 
UIs reflect space for policy change and potential changes 
in spending as determined by key policy and decision 
makers.
In addition to these UIs, four limitations to this 
research should be noted. First, the underlying 
retrospective data include measurement error and 
imputation. Precise data that are comparable across time 
and across countries, and are complete for a long time 
period and all countries, are not available. The 
measurement of out-of-pocket spending and prepaid 
private spending is particularly challenging in countries 
without precise expenditure tracking or where informal 
payments (under the table or black market) make up a 
major share of health spending. This research relies on 
the best data available, although it is not without its flaws. 
When forecasting, measurement error is likely to be 
exacerbated, which is why we prefer wide UIs that mark 
a great deal of variation.
Second, expected health spending for 2040 is based on 
past trends and relationships. These projections are based 
on empirical relationships that are observed between 1995 
and 2014, across 184 countries. We model relationships 
associated with country trends, economic development, 
fiscal shocks, and the demographic transition, but cannot 
anticipate policy or environmental changes that have not 
been observed in our retrospective data. This research 
does not address novel policies that skirt observed historic 
norms, potential environmental changes and challenges, 
and technological innovations in excess of the innovations 
observed during the last 20 years.
Third, stochastic frontier analyses are just one method 
to implement peer country comparisons. Other methods 
such as data envelope analysis or simple calculations of 
the mean, median, and various percentiles in spending 
ratios, constitute other potential approaches. We chose 
stochastic frontier analysis because this technique allows 
for data measurement error and considers a broader 
range of peer countries on which to base the frontier. 
Additionally, we used a half-normal distribution of 
residual for our stochastic frontier. Alternatives for this 
assumption exist as well. Robustness analyses presented 
in the appendix show that although country-specific 
results vary, the primary conclusions of this analysis 
persist across these modelling choices.
Fourth, it is crucial to understand that the frontier 
analysis presented in this research is based exclusively 
on one input. The frontiers used to identify potential 
national health spending and potential all-sector 
government spending are based on expected GDP per 
capita, whereas the frontier used to identify potential 
government health spending is based on expected 
all-sector government spending. These are long-term 
counterfactuals and do not consider the short-run 
realities more thoroughly explored in fiscal space 
analyses. Issues related to debt, government capacity, 
structure of the economy, demand, health system 
efficiency, disease burden, and population age structure 
are also excluded from in this analysis.
In conclusion, variation in GDP and health spending is 
expected to persist through 2040. Past trends and 
relationships suggest that health spending levels will 
continue to diverge globally and even within income 
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groups. Increases in spending to reflect potential levels, as 
determined by GDP per capita and peer nations, would 
lead to more resources for health. However, the pathways 
to ensure these increases vary from country to country. 
This analysis can inform decision makers about possible 
methods to mobilise funds for health, given their country’s 
level of development and financing environment. Despite 
expected increases in spending, this spending in some 
places will probably be insufficient to meet complex health 
needs, underlining the ongoing role of development 
assistance for health in some countries. Insights into 
spending trajectories and financing gaps are crucial as 
health stakeholders face the ambitious SDG agenda and 
the push towards universal health coverage.
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